Introduction {#s1}
============

The expansion of the neocortex in the course of human evolution provides an essential basis for our cognitive abilities ([@bib70]; [@bib4]; [@bib62]; [@bib46]; [@bib9]; [@bib15]; [@bib37]; [@bib24]; [@bib17]; [@bib53]; [@bib68]). This expansion ultimately reflects an increase in the proliferative capacity of the neural stem and progenitor cells in the developing human neocortex (from now on collectively referred to as cortical neural progenitor cells, cNPCs) ([@bib4]; [@bib62]; [@bib46]; [@bib9]; [@bib24]; [@bib5]; [@bib17]; [@bib53]), as well as in the duration of their proliferative, neurogenic and gliogenic phases ([@bib42]; [@bib55]). It is therefore a fundamental task to elucidate the underlying molecular basis, that is, the changes in our genome that endow human cNPCs with these neocortical expansion-promoting properties.

One approach toward this goal is to identify which of the genes that are particularly active in human cNPCs exhibit a human-specific expression pattern, or even are human-specific. We previously isolated, and determined the transcriptomes of, two major cNPC types from embryonic mouse and fetal human neocortex ([@bib25]), (i) the apical (or ventricular) radial glia (aRG), the primary neuroepithelial cell-derived apical progenitor type ([@bib41]; [@bib31]), and (ii) the basal (or outer) radial glia (bRG), the key type of basal progenitor implicated in neocortical expansion ([@bib46]; [@bib9]; [@bib8]; [@bib10]; [@bib24]) ([Figure 1A](#fig1){ref-type="fig"}). This led to the identification of 263 protein-coding human genes that are much more highly expressed in human bRG and aRG than in a neuron-enriched fraction ([@bib25]). Of these, 207 genes have orthologs in the mouse genome but are not expressed in mouse cNPCs, whereas 56 genes lack mouse orthologs. Among the latter, the gene with the highest specificity of expression in bRG and aRG was found to be *ARHGAP11B*, a human-specific gene ([@bib63]; [@bib71]; [@bib3]; [@bib18]) that we showed to be capable of basal progenitor amplification in embryonic mouse neocortex, which likely contributed to the evolutionary expansion of the human neocortex ([@bib25]; [@bib26]).

![A screen for human cNPC-enriched protein-coding genes and determination which of them have orthologs only in primates.\
(**A**) Cartoon illustrating the main zones and neural cell types in the fetal human cortical wall that were screened for differential gene expression in the human transcriptome datasets as depicted in (**B**). Adapted from ([@bib27]). SP, subplate; MZ, marginal zone. (**B**) The indicated five published transcriptome datasets from fetal human neocortical tissue ([@bib23]; [@bib51]) and cell populations ([@bib25]; [@bib36]; [@bib59]), were screened for protein-coding genes showing higher levels of mRNA expression in the indicated germinal zones and cNPC types than in the non-proliferative zones and neurons. (**C**) Heat map showing a pairwise comparison of the degree of overlap between the five gene sets of human genes with preferential expression in cNPCs. (**D**) Venn diagram showing the gene sets of human protein-coding genes displaying the differential gene expression pattern depicted in (**B**). Numbers within the diagram indicate genes found in two (violet), three (pink), four (orange) or all five (yellow) gene sets. Genes found in at least two gene sets were considered as being cNPC-enriched. (**E**) Selected genes with established biological roles found in two, three, four, or all five gene sets. (**F**) GO term analysis of human cNPC-enriched genes. The top three most enriched terms for the category *Cellular Component* (black bars) and for the category *Biological Process* (grey bars) are shown. (**G**) Stepwise analysis leading from the 3458 human cNPC-enriched protein-coding genes to the identification of 50 primate-specific genes.](elife-32332-fig1){#fig1}

Our previous finding that, in addition to *ARHGAP11B*, 55 other human genes without mouse orthologs are predominantly expressed in bRG and aRG ([@bib25]), raises the possibility that some of these genes also may be human-specific and may affect the behaviour of human cNPCs. To investigate the evolution and cell-type specificity of expression of such genes, we have now data-mined our previous dataset ([@bib25]) as well as four additional ones ([@bib23]; [@bib51]; [@bib36]; [@bib59]) to carry out a comprehensive screen for protein-coding genes preferentially expressed in cNPCs of fetal human neocortex. We find that, in addition to *ARHGAP11B*, 14 other human-specific genes show preferential expression in cNPCs. Furthermore, we identify 35 additional human genes exhibiting such expression for which orthologs are found in primate but not in non-primate mammalian genomes. We provide information on the evolutionary mechanisms leading to the origin of several of these primate-specific genes, including gene duplication and transposition. Moreover, we analyze the cell-type expression patterns of most of the human-specific genes, including expression of their splice variants. By comparing the expression of the human-specific genes with their respective ancestral paralog, we show a substantial degree of gene expression divergence upon gene duplication. Finally, we show that expressing the human-specific cNPC-enriched *NOTCH2NL* gene in embryonic mouse neocortex promotes basal progenitor proliferation. Our study thus provides a resource of genes that are candidates to exert specific roles in the development and evolution of the primate, and notably human, neocortex.

Results {#s2}
=======

Screen of distinct transcriptome datasets from fetal human neocortex for protein-coding genes preferentially expressed in neural stem and progenitor cells {#s2-1}
----------------------------------------------------------------------------------------------------------------------------------------------------------

To identify genes preferentially expressed in the cNPCs of the fetal human neocortex, we analyzed five distinct, published transcriptome datasets obtained from human neocortical tissue ranging from 13 to 21 weeks post-conception (wpc). First, the RNA-Seq data obtained from specific neocortical zones isolated by laser capture microdissection (LCM) ([@bib23]), which we screened for all protein-coding genes that are more highly expressed in the VZ, iSVZ and/or oSVZ than the cortical plate (CP) ([Figure 1A,B](#fig1){ref-type="fig"}). This yielded 2780 genes ([Figure 1D](#fig1){ref-type="fig"}). Second, the Allen Brain Institute microarray data (BrainSpan Atlas) obtained from LCM-isolated specific neocortical zones ([@bib51]) ([Figure 1A,B](#fig1){ref-type="fig"}), which we screened for all protein-coding genes with positive laminar correlation with either the VZ, iSVZ or oSVZ as compared to the zones enriched in postmitotic cells (intermediate zone (IZ), subplate, CP, marginal zone, subpial granular zone). This yielded 3802 genes ([Figure 1D](#fig1){ref-type="fig"}). Third, the RNA-Seq data obtained from specific neocortical cell types isolated by fluorescence-activated cell sorting (FACS) ([@bib25]), which we screened for all protein-coding genes more highly expressed in aRG and/or bRG in S-G2-M as compared to the cell population enriched in postmitotic neurons but also containing bRG in G1 ([Figure 1A,B](#fig1){ref-type="fig"}). This yielded 2030 genes ([Figure 1D](#fig1){ref-type="fig"}). Fourth, the data obtained from single-cell RNA-Seq of dissociated cells captured from microdissected VZ and SVZ ([@bib59]), which we screened for all protein-coding genes positively correlated with either radial glial cells, bIPs or both ([Figure 1A,B](#fig1){ref-type="fig"}) and negatively correlated with neurons. This yielded 4391 genes ([Figure 1D](#fig1){ref-type="fig"}). Fifth, the transcriptome-wide RNA-Seq data obtained from specific neocortical cell types isolated by FACS ([@bib36]), which we screened for all protein-coding genes more highly expressed in aRG and/or bRG as compared to the cell population enriched in bIPs and neurons ([Figure 1A,B](#fig1){ref-type="fig"}). This yielded 1617 genes ([Figure 1D](#fig1){ref-type="fig"}).

Since these transcriptome datasets were obtained using different cell identification and isolation strategies (i.e. LCM, FACS, single-cell capture), gestational ages (13--21 wpc), and sequencing technologies (i.e. RNA-Seq, microarray, single-cell RNA-seq) (see [Supplementary file 1](#supp1){ref-type="supplementary-material"} for details), we investigated to what extent the sets of genes preferentially expressed in cNPCs overlapped across datasets ([Figure 1B,C](#fig1){ref-type="fig"}). Pairwise comparison of these cNPC-enriched gene sets revealed a substantial overlap between datasets, ranging from 32% (Florio-Pollen) to 60% (Fietz-Miller) ([Figure 1C](#fig1){ref-type="fig"}). Thus, despite the differences in the experimental approaches used to generate the original datasets, a substantial proportion of the protein-coding genes here identified using the above-described criteria were the same.

Next, we determined how many of the protein-coding genes exhibiting the above-described differential expression pattern were found in all five gene sets. This was the case for 562 genes ([Figure 1D](#fig1){ref-type="fig"}, yellow). We also determined the number of genes found in four of the five gene sets (five combinations, [Figure 1D](#fig1){ref-type="fig"}, orange), in three of the five gene sets (10 combinations, [Figure 1D](#fig1){ref-type="fig"}, pink) and in two of the five gene sets (10 combinations, [Figure 1D](#fig1){ref-type="fig"}, violet). Together this yielded a catalogue of 3458 human genes with preferential expression in cNPCs in at least two gene sets (from here on referred to as cNPC-enriched genes) (see [Supplementary file 1](#supp1){ref-type="supplementary-material"}).

These 3458 genes included many canonical markers of cNPCs and known molecular players involved in (i) function of radial glia (e.g. *FABP7, GFAP, NES, VIM, PROM* ([@bib72]), *PAX6* ([@bib54]; [@bib78])*, SOX2* ([@bib46]), *HOPX* ([@bib59])) and intermediate progenitors (e.g. *EOMES* ([@bib22]), *NEUROG1/2* ([@bib28]; [@bib65])), (ii) cell proliferation (e.g. *MKI67*, *PCNA*), (iii) Notch signaling (e.g. *DLL1, HES1, HES5, NOTCH1, NOTCH3* ([@bib38]; [@bib35])), and (iv) extracellular matrix and growth factor signaling (e.g. *EGF, FGFR2, FGFR3* ([@bib75])*, ITGAV* ([@bib69]), *TGFB1*, *TNC* ([@bib83])) (listed in [Figure 1E](#fig1){ref-type="fig"}). Moreover, several genes recently implicated in human-specific aspects of cNPC proliferation and neocortex formation ([@bib30]; [@bib47]; [@bib5]; [@bib27]; [@bib32]; [@bib52]; [@bib68]) (e.g. *ARHGAP11B, FOXP2, FZD8, GPR56, PDGFD*) were found in the analyzed gene sets, although not necessarily in all five ([Figure 1E](#fig1){ref-type="fig"}).

We validated the set of 3458 cNPC-enriched genes by performing a gene ontology (GO) term enrichment analysis (see [Figure 1D](#fig1){ref-type="fig"} and [Supplementary file 1](#supp1){ref-type="supplementary-material"}). This revealed that for the category *Biological Process* the GO terms 'cell cycle phase and mitotic cell cycle phase', 'mitotic prometaphase' and 'M phase and mitotic M phase' were the three most enriched ones, and for the category *Cellular Component* the GO terms 'chromosome centromeric region', 'condensed chromosome centromeric region' and 'kinetochore' were the three most enriched ones ([Figure 1F](#fig1){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}). This underscored that the cNPC-enriched genes identified here preferentially encode proteins involved in cell division, including core components of the mitotic machinery.

The catalog of the 3458 cNPC-enriched human genes presented here ([Supplementary file 1](#supp1){ref-type="supplementary-material"}) provides a resource (i) to interrogate the cNPC enrichment of candidate genes of interest and (ii) to potentially uncover new genes involved in cNPC function during fetal human corticogenesis.

Identification of primate-specific genes {#s2-2}
----------------------------------------

Primate-specific, notably human-specific, genes expressed in cNPCs have gained increasing attention for their potential role in species-specific aspects of neocortical development, including neurogenesis ([@bib16]; [@bib18]; [@bib27]; [@bib32]; [@bib68]). To determine how many of the 3458 human cNPC-enriched protein-coding genes have orthologs only in primates but not in non-primate species, we excluded from this gene set all those genes with an annotated one-to-one ortholog in any of the sequenced non-primate genomes ([Figure 1G](#fig1){ref-type="fig"}). This greatly reduced the number of genes from 3458 to 77 genes.

Next, we examined these 77 genes to extract those that are truly primate-specific. By inspecting genomic alignments, gene neighborhoods and gene annotations in primate and non-primate mammals, we concluded that 27 of these genes likely have an ortholog in non-primate mammals and we therefore excluded them from further analysis. The remaining 50 genes were considered to be truly primate-specific ([Figure 1G](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) and are of special interest as they may have contributed to neocortical expansion during primate evolution.

Phylogenetic analysis of the primate-specific genes {#s2-3}
---------------------------------------------------

To trace the evolution of the 50 primate-specific genes and to infer their ancestry, we investigated in which species these genes exhibit an intact reading frame and used this information to assign each gene to a primate clade. First, we found that 25 of these 50 genes predate the ape (Hominoidea) ancestor and that 14 of these 25 genes encode zinc finger proteins ([Figure 2A](#fig2){ref-type="fig"}, [Table 1](#table1){ref-type="table"} and [Supplementary file 3](#supp3){ref-type="supplementary-material"}). Remarkably, 15 of the remaining 25 genes that postdate the ape ancestor are only present in the human genome, and thus arose (or evolved to their present state) in the human lineage after its split from the lineage leading to the chimpanzee ([Figure 2A](#fig2){ref-type="fig"}, [Table 1](#table1){ref-type="table"} and [Supplementary file 3](#supp3){ref-type="supplementary-material"}) (\~5--7 Mya, ([@bib13]; [@bib76]; [@bib14])). These 15 human-specific genes include *ARHGAP11B*, a gene that we reported previously to promote cNPC proliferation and neocortex expansion ([@bib25]; [@bib26]) and that was also present in the archaic genomes of Neandertals and Denisovans ([@bib71]; [@bib50]; [@bib3]; [@bib61]; [@bib25]).

![Occurrence of the primate-specific genes in the various primate clades.\
(**A**) Assignment of the 50 primate-specific genes to a primate clade, based on the primate genome(s) in which an intact reading frame was found in the present analysis. Clades are specified on the top left. The color-coding and brackets indicate the species in each clade analyzed in the present study. Numbers on top of the brackets indicate the number of genes assigned to that clade. Note that the occurrence of the genes in the various clades does not necessarily apply to every species in the clade. (**B**) Diagram depicting the number of new cNPC-enriched genes as a function of the frequency of occurrence of neutral base pair substitutions in the eight different branches leading to these various clades (branch length). Numbered dots indicate the branches shown in panel (**A**). Red dots indicate the branches with disproportionately high rates of appearance of new cNPC-enriched genes.](elife-32332-fig2){#fig2}
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###### Primate-specific genes

  Gene symbol       Gene name                                                          Function                                                                                                                                                                                                                                                                                                                                                                                                          cNPC-enriched in                 Occurrence                                 Features
  ----------------- ------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------- ------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ***ANKRD20A2***   Ankyrin repeat domain 20 family member A2                          Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Pollen, Miller           Homo (before Neandertal-Denisovan split)   Five ankyrin repeats, three coiled coil motifs \[UniProt\]
  ***ANKRD20A4***   Ankyrin repeat domain 20 family member A4                          Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Fietz, Pollen            Homo (before Neandertal-Denisovan split)   Five ankyrin repeats, three coiled coil motifs \[UniProt\]
  ***ARHGAP11B***   Rho GTPase activating protein 11B                                  Basal progenitor amplification ([@bib25])                                                                                                                                                                                                                                                                                                                                                                         Florio, Fietz, Pollen            Homo (before Neandertal-Denisovan split)   One nucleotide substitution led to a novel splice donor site in exon five resulting in a novel and unique C-terminal sequence and a loss of Rho-GAP activity ([@bib25]; [@bib26])
  ***CBWD6***       COBW Domain Containing 6                                           Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Pollen, Miller                   Homo (before Neandertal-Denisovan split)   CobW domain, ATP binding sites \[UniProt\]
  ***DHRS4L2***     Dehydrogenase/reductase 4 like 2                                   Maybe an NADPH dependent retinol oxidoreductase \[RefSeq\]                                                                                                                                                                                                                                                                                                                                                        Fietz, Pollen                    Homo (before Neandertal-Denisovan split)   Unknown
  ***FAM182B***     Family with sequence similarity 182 member B                       Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Fietz, Miller                    Homo (before Neandertal-Denisovan split)   Removal of a stop codon resulting in an open reading frame in humans (this publication)
  ***FAM72B***      Family with sequence similarity 72 member B                        Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Fietz, Pollen            Homo (before Neandertal-Denisovan split)   Unknown
  ***FAM72C***      Family with sequence similarity 72 member C                        Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Fietz, Pollen            Homo (before Neandertal-Denisovan split)   Unknown
  ***FAM72D***      Family with sequence similarity 72 member D                        Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Fietz, Miller            Homo (before Neandertal-Denisovan split)   Unknown
  ***GTF2H2C***     GTF2H2 family member C                                             Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Pollen, Miller                   Homo (before Neandertal-Denisovan split)   VWFA domain, C4-type zinc finger motif \[UniProt\]
  ***NBPF10***      Neuroblastoma Breakpoint Family Member 10                          Contains DUF1220 domains which have been implicated in a number of developmental and neurogenetic diseases (e.g. microcephaly, macrocephaly, autism, schizophrenia, cognitive disability, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies) \[RefSeq\]                                                                                                                  Fietz, Pollen                    Homo (before Neandertal-Denisovan split)   Tandemly repeated copies of DUF1220 protein domains \[RefSeq\], coiled coil domain \[UniProt\]
  ***NBPF14***      Neuroblastoma Breakpoint Family Member 14                          Contains DUF1220 domains which have been implicated in a number of developmental and neurogenetic diseases (e.g. microcephaly, macrocephaly, autism, schizophrenia, cognitive disability, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies) \[RefSeq\]                                                                                                                  Fietz, Pollen                    Homo (before Neandertal-Denisovan split)   Tandemly repeated copies of DUF1220 protein domains \[RefSeq\], coiled coil domain \[UniProt\]
  ***NOTCH2NL***    Notch 2 N-terminal like                                            Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Fietz, Pollen            Homo (before Neandertal-Denisovan split)   6 EGF-like domains \[UniProt\]
  ***SMN2***        Survival of motor neuron 2, centromeric                            Loss of *SMN1* and *SMN2* results in embryonic death; mutations in *SMN1* are associated with spinal muscular atrophy, mutations in *SMN2* do not lead to disease; forms heteromeric complexes with proteins such as SIP1 and GEMIN4, and also interacts with several proteins known to be involved in the biogenesis of snRNPs, such as hnRNP U protein and the small nucleolar RNA binding protein \[RefSeq\]   Pollen, Miller                   Homo (after Neandertal-Denisovan split)    Evolved after the split from Neanderthal and Denisovan ([@bib18]); telomeric (*SMN1*) and centromeric (*SMN2*) copies of this gene are nearly identical and encode the same protein; critical sequence difference between the two genes is a single nucleotide in exon 7, which is thought to be an exon splice enhancer; the full length protein encoded by this gene localizes to both the cytoplasm and the nucleus \[RefSeq\]; GEMIN2 binding site, tudor domain, RPP20/POP7 interaction site, SNRPB binding site, SYNCRIP interaction site \[UniProt\]
  ***ZNF492***      Zinc finger protein 492                                            Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Fietz, Pollen            Homo (before Neandertal-Denisovan split)   Human ZNF492 is a chimera consisting of the original KRAB repressor domain and the acquired ZNF98 DNA binding domain (this publication); KRAB domain and 13 C2H2 zinc finger motifs \[UniProt\]
  ***ALG1L***       ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like   Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Pollen, Miller                   Hominini                                   Unknown
  ***CBWD2***       COBW domain containing 2                                           Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Pollen, Miller                   Hominini                                   CobW domain, ATP binding sites \[UniProt\]
  ***TMEM133***     Transmembrane protein 133                                          Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Fietz, Miller, Johnson           Hominini                                   Intronless gene \[RefSeq\]; transmembrane protein without signal peptide and two predicted transmembrane domains (Protter)
  ***HHLA3***       HERV-H LTR-associating 3                                           Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Fietz, Pollen                    Homininae                                  Unknown
  ***TMEM99***      Transmembrane protein 99                                           Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Fietz, Miller                    Hominidae                                  Transmembrane protein with signal peptide and three transmembrane domains \[UniProt, Protter\]
  ***ZNF90***       Zinc finger protein 90                                             Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Pollen                   Hominidae                                  KRAB domain and 15 C2H2 zinc finger motifs \[UniProt\]
  ***CCDC74B***     Coiled-coil domain containing 74B                                  Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Fietz, Pollen, Miller, Johnson   Hominoidae                                 Coiled-coil motif \[UniProt\]
  ***C9orf47***     Chromosome nine open reading frame 47                              Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Fietz, Miller, Johnson           Hominoidae                                 Signal peptide \[UniProt, Protter\]
  ***GLUD2***       Glutamate Dehydrogenase 2                                          Localized to the mitochondrion, homohexamer, recycles glutamate during neurotransmission and catalyzes the reversible oxidative deamination of glutamate to alpha-ketoglutarate \[RefSeq\]                                                                                                                                                                                                                        Miller, Johnson                  Hominoidae                                 Arose by retroposition (intronless) (this publication)
  ***PTTG2***       Pituitary tumor-transforming 2                                     Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Fietz, Miller                    Hominoidae                                 Arose by retroposition; reading frame remained open only in apes (this publication); destruction box, SH3 binding domain \[UniProt\]
  ***APOL2***       Apolipoprotein L2                                                  Is found in the cytoplasm, where it may affect the movement of lipids or allow the binding of lipids to organelles \[RefSeq\]                                                                                                                                                                                                                                                                                     Florio, Fietz, Pollen, Johnson   Catarrhini                                 Signal peptide \[UniProt, Protter\]
  ***APOL4***       Apolipoprotein L4                                                  May play a role in lipid exchange and transport throughout the body, as well as in reverse cholesterol transport from peripheral cells to the liver \[RefSeq\]                                                                                                                                                                                                                                                    Fietz, Miller                    Catarrhini                                 Signal peptide \[UniProt, Protter\]
  ***BTN3A2***      Butyrophilin subfamily three member A2                             Immunoglobulin superfamily, may be involved in the adaptive immune response \[RefSeq\]                                                                                                                                                                                                                                                                                                                            Fietz, Pollen, Miller            Catarrhini                                 Signal peptide, Ig-like V-type domain, coiled coil motif, one transmembrane domain \[UniProt, Protter\]
  ***BTN3A3***      Butyrophilin Subfamily 3 Member A3                                 Major histocompatibility complex (MHC)-associated gene                                                                                                                                                                                                                                                                                                                                                            Fietz, Miller                    Catarrhini                                 Arose by triplication duplication: BTN3A1 is likely the ancestral gene, BTN3A1 duplicated once and this \'copy\' duplicated to BTN3A2 and BTN3A3. This triplication happened in the human-rhesus ancestor since marmoset has only a single gene (this publication); type I membrane protein with two extracellular immunoglobulin (Ig) domains and an intracellular B30.2 (PRYSPRY) domain \[UniProt\]
  ***MICA***        MHC class I polypeptide-related sequence A                         Is a ligand for the NKG2-D type II integral membrane protein receptor; functions as a stress-induced antigen that is broadly recognized by intestinal epithelial gamma delta T cells; variations have been associated with susceptibility to psoriasis one and psoriatic arthritis \[RefSeq\]                                                                                                                     Florio, Fietz, Miller            Catarrhini                                 Signal peptide, Ig-like C1-type domain, one transmembrane domain \[UniProt, Protter\]
  ***MT1M***        Metallothionein 1M                                                 Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Miller, Johnson                  Catarrhini                                 Two metal-binding domains \[UniProt\]
  ***SLFN13***      Schlafen Family Member 13                                          Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Johnson                  Catarrhini                                 Unknown
  ***ZNF100***      Zinc finger protein 100                                            Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Fietz, Pollen                    Catarrhini                                 KRAB domain and 12 C2H2 zinc finger motifs \[UniProt\]
  ***ZNF222***      Zinc Finger Protein 222                                            Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Pollen, Miller                   Catarrhini                                 KRAB domain and 10 C2H2 zinc finger motifs \[UniProt\]
  ***ZNF43***       Zinc finger protein 43                                             Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Fietz, Pollen                    Catarrhini                                 KRAB domain and 22 C2H2 zinc finger motifs \[UniProt\]
  ***ZNF695***      Zinc finger protein 695                                            Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Fietz, Miller            Catarrhini                                 KRAB domain and 13 C2H2 zinc finger motifs \[UniProt\]
  ***ZNF724***      Zinc finger protein 724                                            Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Fietz, Pollen            Catarrhini                                 KRAB domain and 16 C2H2 zinc finger motifs \[UniProt\]
  ***ZNF726***      Zinc finger protein 726                                            Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Fietz                    Catarrhini                                 KRAB domain and 20 C2H2 zinc finger motifs \[UniProt\]
  ***ZNF730***      Zinc finger protein 730                                            Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Fietz, Johnson                   Catarrhini                                 KRAB domain and 12 C2H2 zinc finger motifs \[UniProt\]
  ***ZNF732***      Zinc finger protein 732                                            Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Pollen                   Catarrhini                                 KRAB domain and 16 C2H2 zinc finger motifs \[UniProt\]
  ***ZNF816***      Zinc finger protein 816                                            Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Fietz, Pollen, Miller    Catarrhini                                 KRAB domain and 15 C2H2 zinc finger motifs \[UniProt\]
  ***ZNF93***       Zinc finger protein 93                                             Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Pollen, Miller                   Catarrhini                                 KRAB domain and 17 C2H2 zinc finger motifs \[UniProt\]
  ***HEPN1***       Hepatocellular carcinoma, down-regulated 1                         Transient expression of this gene significantly inhibits cell growth and suggests a role in apoptosis; downregulated or lost in hepatocellular carcinomas \[RefSeq\]                                                                                                                                                                                                                                              Florio, Fietz, Miller            Simiiformes                                Expressed in the liver; encodes a short peptide, predominantly localized to the cytoplasm \[RefSeq\]
  ***KIF4B***       Kinesin family member 4B                                           A microtubule-based motor protein that plays vital roles in anaphase spindle dynamics and cytokinesis \[RefSeq\]                                                                                                                                                                                                                                                                                                  Fietz, Pollen                    Simiiformes                                Intronless retrocopy of kinesin family member 4A \[RefSeq\]; kinesin motor domain, ATP binding site, coiled coil, nuclear localization signal, PRC1 interaction domain \[UniProt\]
  ***ZNF20***       Zinc finger protein 20                                             Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Fietz, Miller                    Simiiformes                                KRAB domain and 15 C2H2 zinc finger motifs \[UniProt\]
  ***ZNF680***      Zinc finger protein 680                                            Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Florio, Pollen                   Simiiformes                                KRAB domain and 12 C2H2 zinc finger motifs \[UniProt\]
  ***ZNF718***      Zinc finger protein 718                                            Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Fietz, Pollen                    Simiiformes                                KRAB domain and 11 C2H2 zinc finger motifs \[UniProt\]
  ***ZNF788***      Zinc finger family member 788                                      Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Fietz, Pollen                    Simiiformes                                No KRAB domain, 17 C2H2 zinc finger motifs \[UniProt\]
  ***MT1E***        Metallothionein 1E                                                 Unknown                                                                                                                                                                                                                                                                                                                                                                                                           Pollen, Miller                   Haplorrhini                                Two metal-binding domains \[UniProt\]
  ***TNFRSF10D***   TNF receptor superfamily member 10d                                Does not induce apoptosis and has been shown to play an inhibitory role in TRAIL-induced cell apoptosis. \[RefSeq\]                                                                                                                                                                                                                                                                                               Florio, Fietz                    Haplorrhini                                Signal peptide, TRAIL-binding domain, one transmembrane domain, truncated death domain \[UniProt, Protter\]

Similar to *ARHGAP11B*, 13 of the remaining 14 human-specific genes existed also in the genomes of Neandertals and Denisovans ([@bib71]; [@bib18]) and present data (see [Table 1](#table1){ref-type="table"}) and thus arose before the split of the lineages leading to modern humans vs. Neandertals/Denisovans \~500,000 years ago ([@bib50]; [@bib61]). The only one of the 15 human-specific genes that has been reported to have arisen in the lineage leading to modern humans after its divergence from the lineage leading to Neandertals and Denisovans is *SMN2* ([@bib18]). The *SMN2* gene can alleviate spinal muscular atrophy, a neurological disease caused by mutations of *SMN1* (the ancestral paralog of *SMN2*) ([@bib56]; [@bib45]; [@bib79]), and thus can be regarded as an, albeit inefficient, *SMN1* back-up specific to modern humans.

Next, we asked whether the rate at which new cNPC-enriched genes arose during primate evolution was relatively constant, or whether there were perhaps bursts in the appearance of new cNPC-enriched genes at certain steps during primate evolution. To address this question, we plotted the number of new cNPC-enriched genes that appeared in the various primate clades as a function of the length of the respective branch (see [Figure 2A](#fig2){ref-type="fig"}) (measured as the rate of neutral base pair substitutions). This revealed a disproportionately high rate of appearance of new cNPC-enriched genes in two of the branches, the branch that leads to Catarrhini (branch 6) and the branch that leads to human (branch 1) ([Figure 2B](#fig2){ref-type="fig"}).

Analysis of selected primate-specific genes reveals distinct evolutionary mechanisms {#s2-4}
------------------------------------------------------------------------------------

Next, we examined how these 50 primate-specific genes evolved. We first focused on three primate-specific genes that are not human-specific, which we selected in light of their potential biological role -- *MICA*, *KIF4B* and *PTTG2*.

*MICA* (*MHC class I polypeptide-related sequence A*) is the only gene among the 50 primate-specific genes analyzed in the present study that has an established relationship to the MHC locus ([@bib6]), pointing to a possible primate-specific interaction between cNPCs and cells of the immune system. *MICA* is a paradigmatic example of a gene arising by gene duplication ([@bib7]; [@bib21]; [@bib29]; [@bib34]), a well-known driving force of genome evolution ([@bib48]). *MICA* arose by duplication of the *MICB* gene, and this event occurred in the Catarrhini ancestor ([Figure 2A](#fig2){ref-type="fig"}).

Besides gene duplication, however, other mechanisms were found to contribute to the evolution of primate-specific genes. A notable example is *KIF4B* (*Kinesin Family Member 4B)*, a gene encoding a kinesin involved in spindle organization during cytokinesis ([@bib82]). In fact, *KIF4B* is the only member of the kinesin superfamily among the 50 primate-specific genes. *KIF4B* evolved in the Simiiformes ancestor ([Figure 2A](#fig2){ref-type="fig"}) by retroposition of *KIF4A*, a gene with a near-ubiquitous occurrence in the animal kingdom ([@bib33]). This retroposition involved the reverse transcription of a spliced *KIF4A* mRNA followed by insertion of the DNA into the genome as an intronless copy of *KIF4A*.

The third gene we analyzed was *PTTG2* (*pituitary tumor transforming 2*), as its paralog *PTTG1* encodes a tumorigenic protein implicated in promoting proliferation of pituitary tumor cells ([@bib19]; [@bib81]; [@bib77]). Similar to *KIF4B*, the primate-specific gene *PTTG2* arose by retroposition of a reverse transcribed spliced mRNA of *PTTG1*, a gene encompassing five protein-coding exons that are conserved in reptiles, birds and mammals. However, while *KIF4B* inserted into an intergenic locus (that however allowed its transcription), the intronless protein-coding *PTTG2* inserted in sense direction into intron 2 of the *TBC1D1* gene ([Figure 3A](#fig3){ref-type="fig"}), which encodes a Rab-GTPase activating protein ([@bib64]). Remarkably, whereas the *PTTG2* retroposition event already occurred in the Simiiform ancestor, the *PTTG2* gene underwent two principally different lines of evolution after retroposition. In all non-Hominoidea Simiiformes (see [Figure 2A](#fig2){ref-type="fig"}), consistent with neutral evolution, *PTTG2* accumulated frameshifting deletions and translational stop codon mutations that cause a premature termination of the open-reading frame ([Figure 3B](#fig3){ref-type="fig"}). In contrast, in Hominoidea (apes and humans, see [Figure 2A](#fig2){ref-type="fig"}), the *PTTG2* reading frame remained open, with one noticeable change. This is a 1 bp insertion (T, see [Figure 3A](#fig3){ref-type="fig"}) near the 3' end of the *PTTG2* open-reading frame that causes a shift in the reading frame, resulting in a new 13-amino acid-long C-terminal sequence of PTTG2 in great apes (including human) (as opposed to 24 amino acids in PTTG1) ([Figure 3B](#fig3){ref-type="fig"}). This PTTG2-specific sequence lacks the cluster of acidic residues found in the C-terminal sequence of PTTG1. In the case of the gibbon, however, the *PTTG2* gene carries (in addition to the 1 bp T insertion) a 22 bp deletion a few nucleotides 5' to this insertion. This causes yet another shift in the reading frame that results in the replacement of the C-terminal 25 amino acids of the PTTG2 of great apes (including human) by an 18-amino acid-long sequence ([Figure 3B](#fig3){ref-type="fig"}). The potential consequences of these changes in protein sequence for the function of PTTG2 with regard to cell proliferation are discussed below.

![Evolutionary origin of the *PTTG2* gene.\
(**A**) Origin of the *PTTG2* gene by reverse transcription of the *PTTG1* mRNA and insertion as a retroposon into the *TBC1D1* locus in the ancestor to New-World monkeys, Old-World monkeys and apes (Simiiformes). (**B**) Comparison of the PTTG1 and Hominoidea PTTG2 polypeptides, and of the prematurely closed open-reading frames of non-ape Simiiformes *PTTG2*.](elife-32332-fig3){#fig3}

Evolutionary mechanisms that gave rise to the human-specific cNPC-enriched protein-coding genes {#s2-5}
-----------------------------------------------------------------------------------------------

We next investigated how the 15 human-specific cNPC-enriched protein-coding genes evolved. Twelve of them arose by duplications of entire genes ([@bib7]; [@bib21]; [@bib29]; [@bib34]) ([Figure 4A](#fig4){ref-type="fig"}). A special case, illustrating possible evolutionary trajectories after gene duplication, is the human-specific cNPC-enriched *NOTCH2NL* gene ([Figure 4A](#fig4){ref-type="fig"}). It arose from a duplication that included the genes *NBPF7*, *ADAM30*, and *NOTCH2* ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). After the gene duplication event, a deletion occurred that removed the duplicated *ADAM30* gene and a large portion of the duplicated *NOTCH2* gene. This portion included most of the sequence giving rise to the two long *NOTCH2* splice variants (ENST00000256646 and ENST00000579475). The remaining duplicated *NOTCH2* gene sequence (the *NOTCH2NL* gene) gives rise to a short splice variant (ENST00000602566) ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) that encodes only a short segment of the NOTCH2 ectodomain.

![Evolution of the human-specific cNPC-enriched protein-coding genes.\
Diagrams depicting the evolutionary origin of the 15 human-specific genes. (**A**) Duplication of the entire ancestral gene, which applies to 12 of the human-specific genes. *NOTCH2NL* is included in this group because it initially arose by duplication of the entire *NOTCH2* gene. Note that the gene duplication giving rise to *SMN2* occurred after the Neandertal -- modern human lineage split, whereas the other 11 gene duplications occurred before that split ([@bib18]). (**B**) Partial gene duplication giving rise to *ARHGAP11B* \~ 5 Mya ([@bib63]; [@bib3]; [@bib18]). Note that a single C--\>G substitution in exon 5 (red box), which likely occurred after the gene duplication event but before the Neandertal -- modern human lineage split, created a new splice donor site, causing a reading frame shift that resulted in a novel, human-specific 47 amino acid C-terminal sequence ([@bib25]; [@bib26]). (**C**) Exon duplication and replacement giving rise to human *ZNF492*. Exon 4 of *ZNF98* (blue) is duplicated and inserted into intron 3 of *ZNF492* (orange), rendering the original *ZNF492* exon 4 a pseudoexon. (**D**) Removal of a stop codon converting the non-coding *FAM182B* of non-human primates into the protein-coding human *FAM182B*. A single T--\>G substitution removes the stop codon at the 5\' end of exon 3, thereby creating an open reading frame (purple). (**E**) Validation of the human-specific nature of selected human genes by determination of their copy numbers. Human (blue), chimpanzee (orange) and bonobo (yellow) genomic DNA was used as template to perform a qPCR that would generate two distinct amplicons of both, the gene common to all three species (black regular letters) and the human-specific gene(s) under study (red bold letters), as indicated. The relative amounts of amplicons obtained for each of the four gene groups are depicted with the amounts of amplicons obtained with the bonobo genomic DNA as template being set to 1.0. Note that compared to chimpanzee and bonobo genomic DNA, the copy number in human genomic DNA is (**i**) two-fold higher for *ARHGAP11*, consistent with the presence of the human-specific gene *ARHGAP11B* in addition to the common gene *ARHGAP11A*; (ii) four-fold higher for *FAM72*, consistent with the presence of the human-specific genes *FAM72B*, *FAM72C* and *FAM72D* in addition to the common gene *FAM72A*; (iii) three-fold higher for *GTF2H2*, consistent with the presence of the human-specific genes *GTF2H2B* (black bold letters, not among the cNPC-enriched genes identified in this study) and *GTF2H2C* in addition to the common gene *GTF2H2A*; and (iv) two-fold higher for *SMN*, consistent with the presence of the human-specific gene *SMN2* in addition to the common gene *SMN1*.\
10.7554/eLife.32332.010Figure 4---source data 1.Human raw data.This zipped folder contains four data files of human raw data used to generate the graphs presented in [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}. Data file 1: Human raw data (R1) of pool 1. Data file 2: Human raw data (R2) of pool 1. Data file 3: Human raw data (R1) of pool 2. Data file 4: Human raw data (R2) of pool 2.\
10.7554/eLife.32332.011Figure 4---source data 2.Bonobo raw data.This zipped folder contains four data files of bonobo raw data used to generate the graphs presented in[Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}. Data file 5: Bonobo raw data (R1) of pool 1. Data file 6: Bonobo raw data (R2) of pool 1. Data file 7: Bonobo raw data (R1) of pool 2. Data file 8: Bonobo raw data (R2) of pool 2.\
10.7554/eLife.32332.012Figure 4---source data 3.Chimpanzee raw data.This zipped folder contains four data files of chimpanzee raw data used to generate the graphs presented in [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}. Data file 9: Chimpanzee raw data (R1) of pool 1. Data file 10: Chimpanzee raw data (R2) of pool 1. Data file 11: Chimpanzee raw data (R1) of pool 2. Data file 12: Chimpanzee raw data (R2) of pool 2.](elife-32332-fig4){#fig4}

One gene, *ARHGAP11B*, arose by a partial gene duplication ([Figure 4B](#fig4){ref-type="fig"}). Its evolution has been analyzed previously ([@bib63]; [@bib3]; [@bib25]; [@bib26]; [@bib18]; [@bib20]).

The remaining two of the 15 human-specific cNPC-enriched protein-coding genes evolved in distinct ways. The *ZNF492* gene as such exists in the genomes of all non-human great apes. In the case of human, however, an exon of another zinc finger protein-encoding gene, *ZNF98*, inserted into the *ZNF492* locus, yielding a chimeric human-specific protein containing the repressor domain of ZNF492 and the DNA binding domain of ZNF98 ([Figure 4C](#fig4){ref-type="fig"}). The *FAM182B* gene as such exists not only in human but also in chimpanzee, bonobo and gorilla. However, in bonobo and gorilla, a stop codon terminates the potential open-reading frame soon after the initiator methionine, whereas in human a single T--\>G substitution replaces this premature stop with a sense codon to yield a 152-amino acid-long protein ([Figure 4D](#fig4){ref-type="fig"}). In chimpanzee, the T of the TAG stop codon is deleted, which we confirmed by genomic PCR (data not shown), resulting in a reading frame shift that predicts a shorter, 52-amino acid-long polypeptide. Taken together, we conclude that the human-specific cNPC-enriched protein-coding genes evolved mainly by entire or partial gene duplications.

Validation of human-specific gene duplications {#s2-6}
----------------------------------------------

We sought to corroborate that the human-specific cNPC-enriched protein-coding genes arising from complete or partial gene duplication indeed constitute additional gene copies (rather than reflecting the inability of distinguishing multiple gene copies in the genomes of the other great apes due to genome assembly issues). To this end, we used a quantitative genomic PCR approach. The rationale was that primers targeting genomic regions within duplicated loci that are identical in human, chimpanzee and bonobo should amplify genomic DNA of the three species proportionally to the copy number of each gene in each species. As a proof of principle, we validated the known human-specific nature of the partially duplicated *ARHGAP11B* by designing primers to the regions that are identical between *ARHGAP11A* and *ARHGAP11B*. Using the bonobo gene as the standard, this resulted in a two-fold increase of the human PCR product compared to the bonobo and chimpanzee, confirming that *ARHGAP11B* is indeed a human-specific gene duplication ([Figure 4E](#fig4){ref-type="fig"}) and that our approach allows us to estimate copy number variants.

We therefore used the same approach to validate other human-specific genes in our list arising from complete gene duplication. For 7 of these 12 genes (*ANKRD20A2, ANKRD20A4, CBWD6, DHRS4L2, NBPF10, NBPF14*, and *NOTCH2NL*), we could not design primers that uniquely target these genes as the respective genomic loci are not well resolved in the non-human great ape genomes. Thus, the final validation of these putative human-specific genes awaits improved genome assemblies. For the other five human-specific cNPC-enriched genes (*FAM72B/C/D*, *GTF2H2C*, *SMN2*) and for the human-specific gene *GTF2H2B* for which primers could be designed, genomic qPCR resulted in an estimated four human copies of *FAM72* (i.e. the ancestral *FAM72A* plus its three human-specific paralogs *FAM72B/C/D*), three human copies of *GTF2H2* (i.e. the ancestral *GTF2H2* and the two human-specific paralogs *GTF2H2B/C)* and two human copies of *SMN* (i.e. ancestral *SMN1* and its human-specific paralog *SMN2)* ([Figure 4E](#fig4){ref-type="fig"}), compared to only one copy in both chimpanzee and bonobo. This validated the human-specific nature of these genes.

To validate the specificity of the genomic qPCR reactions, we sequenced the amplicons of the above-mentioned seven human-specific genes and their ancestral paralogs from human, bonobo, and chimpanzee genomic DNA. The percentage of the DNA sequence reads of the PCR amplicons that aligned to the targeted genomic sequences ranged from 97.2 to 99.8, indicating that the PCR reactions were highly specific ([Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}). Moreover, the absolute number of DNA sequence reads that aligned to the respective genomic sequence of either one of the seven human-specific genes or its ancestral paralog ([Figure 4---figure supplement 2B](#fig4s2){ref-type="fig"}) corresponded to the gene copy numbers as determined by the genomic qPCR ([Figure 4E](#fig4){ref-type="fig"}). These two sets of data therefore validated the genomic qPCR data.

Spatial mRNA expression analysis in fetal human neocortex of selected primate- and human-specific cNPC-enriched genes {#s2-7}
---------------------------------------------------------------------------------------------------------------------

Given the 15 human-specific genes that had emerged from our screen for cNPC-enriched genes, it was of interest to examine their spatial expression pattern in the various zones of the fetal human cortical wall. To this end, we performed in-situ hybridization (ISH) on 13 wpc human neocortex for 13 of the 15 human-specific cNPC-enriched genes, and for the three above-described primate- but not human-specific genes, to determine the localization of their mRNAs.

We were able to design specific ISH probes for six human-specific genes -- *ARHGAP11B, NOTCH2NL*, *DHRS4L2*, *FAM182B, GTF2H2C* and *ZNF492*. In the case of *ARHGAP11B*, we used a specific Locked Nucleic Acid (LNA) probe, which enabled us to distinguish the mRNA of *ARHGAP11B* from that of *ARHGAP11A* ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). mRNA expression was detected in all three germinal zones (VZ, iSVZ and oSVZ) but not in the CP ([Figure 5B](#fig5){ref-type="fig"}). Expression of *NOTCH2NL* was essentially restricted to the VZ ([Figure 5D](#fig5){ref-type="fig"}). *DHRS4L2* and *ZNF492* were found to be expressed in all three germinal zones and the CP, with a stronger signal in the VZ and iSVZ than in the oSVZ and CP ([Figure 5F,I](#fig5){ref-type="fig"}). *GTF2H2C* mRNA expression was also detected in the three germinal zones and the CP, but with stronger staining in the VZ, iSVZ and CP than in the oSVZ ([Figure 5H](#fig5){ref-type="fig"}). Finally, in the case of *FAM182B*, mRNA expression was stronger in the VZ and CP than in the iSVZ and oSVZ ([Figure 5J](#fig5){ref-type="fig"}).

![In-situ hybridization analysis of the mRNA levels of the human-specific cNPC-enriched protein-coding genes in the various zones of the fetal neocortical wall.\
Coronal sections of human fetal neocortex (13 wpc) were subjected to ISH using probes that (i) are specific for the mRNA of the human-specific gene under study (**B, D, F, H, I, J**), indicated by the gene name with blue background; (ii) recognize the mRNAs of both the human-specific gene(s) and the paralog gene(s) common to other primates as well (**E, G, K, L, M, N**), indicated by gene names with white/blue background; or (iii) are specific to the ancestral paralog (**A, C**), indicated by the gene name with white background. The various zones of the fetal neocortical wall are indicated on the left and by red dashed lines. Green, yellow, and orange boxes indicate areas of the VZ, SVZ and CP, respectively, that are shown at higher magnification in the respective images on the right. Scale bars in A apply to all panels and are 100 µm. Note that an ISH probe yielding a reliable signal for *ZNF98* could not be designed.](elife-32332-fig5){#fig5}

We then sought to compare expression of these human-specific genes with that of their ancestral paralog. We were able to design probes specific to *ARHGAP11A* (ancestral to *ARHGAP11B*) and *NOTCH2* (ancestral to *NOTCH2NL*). The mRNA expression pattern of the ancestral paralog *ARHGAP11A* ([Figure 5A](#fig5){ref-type="fig"}) showed a striking difference to that of the human-specific gene *ARHGAP11B* ([Figure 5A,B](#fig5){ref-type="fig"}). Whereas *ARHGAP11B* expression was largely restricted to the three germinal zones ([Figure 5B](#fig5){ref-type="fig"}), *ARHGAP11A* expression was also detected in the IZ and to some extent the CP ([Figure 5A](#fig5){ref-type="fig"}). Of note, *ARHGAP11A*, in contrast to *ARHGAP11B*, showed a specific ISH signal at the basal surface of the CP, which likely reflects concentration of *ARHGAP11A* mRNA in the basal end-feet of radial glial cells ([Figure 5A,B](#fig5){ref-type="fig"}), a subcellular site at which certain mRNAs can be concentrated ([@bib73]; [@bib58]). In contrast to *ARHGAP11A/B*, mRNA localization of ancestral *NOTCH2* ([Figure 5C](#fig5){ref-type="fig"}) was virtually identical to the expression pattern of human-specific *NOTCH2NL* described above ([Figure 5C,D](#fig5){ref-type="fig"}).

We could not design ISH probes specific to the ancestral copies of *DHRS4L2 (*i.e. *DHRS4)* and *GTF2H2C* (i.e. *GTF2H2*). We therefore designed probes that recognize all paralogs within a given gene family and detect their combined mRNA expression. Specifically, for *DHRS4,* the ancestral paralog, the human-specific *DHRS4L2,* and the other paralog, *DHRS4L1*; for *GTF2H2,* the ancestral paralog, the cNPC-enriched human-specific *GTF2H2C*, and the human-specific, but not cNPC-enriched, *GTF2H2B*. The combined mRNA expression patterns of *DHRS4/L1/L2* were similar to that of *DHRS4L2*, and the combined mRNA expression patterns of *GTF2H2/B/C* were similar to that of *GTF2H2C,* with stronger signal in the VZ and iSVZ than in the oSVZ and CP in both cases ([Figure 5E--H](#fig5){ref-type="fig"}).

In the case of *ANKRD20A2, ANKRD20A4*, *CBWD6*, *FAM72B*, *FAM72C*, *FAM72D*, and *SMN2*, for which we could not design specific probes, we also could not design probes specific to their ancestral paralogs. We therefore used probes recognizing all paralogs in each family and analyzed their combined expression patterns. In the case of *ANKRD20A1-4* (which included the cNPC-enriched human-specific genes *ANKRD20A2* and *ANKRD20A4,* ancestral *ANKRD20A1,* and yet another paralog, *ANKRD20A3*), expression was essentially confined to the VZ ([Figure 5K](#fig5){ref-type="fig"}). In the case of *CBWD1-6* (which included the cNPC-enriched human-specific gene *CBWD6,* ancestral *CBWD1*, and *CBWD2-5*), mRNA expression was stronger in the VZ and CP than iSVZ and oSVZ ([Figure 5L](#fig5){ref-type="fig"}). In the case of *FAM72A-D* (which included the cNPC-enriched human-specific genes *FAM72B*, *FAM72C*, and *FAM72D* and ancestral *FAM72A*), mRNA expression was stronger in the VZ and iSVZ than in the oSVZ and CP ([Figure 5M](#fig5){ref-type="fig"}). A similar expression pattern was found for *SMN1-2* (which included the cNPC-enriched human-specific gene *SMN2* and ancestral *SMN1*) ([Figure 5N](#fig5){ref-type="fig"}).

Finally, we also used ISH to examine the spatial expression pattern in the fetal human cortical wall of the three primate-specific genes *PTTG2*, *MICA* and *KIF4B*. Due to the high degree of similarity in nucleotide sequence this analysis also included the mRNA of the respective ancestral paralog. mRNA expression for *PTTG1/2* ([Figure 6A](#fig6){ref-type="fig"})*, MICA/B* ([Figure 6B](#fig6){ref-type="fig"}) and *KIF4A/B* ([Figure 6C](#fig6){ref-type="fig"}) was robust in the human VZ and iSVZ, relatively low in the oSVZ, and moderate in the CP.

![In-situ hybridization analysis of the mRNA levels of three selected primate-specific genes in the various zones of the fetal human neocortical wall.\
Coronal sections of human fetal neocortex (13 wpc) were subjected to ISH using probes recognizing the mRNAs of the primate-specific genes *PTTG2* (**A**), *MICA* (**B**) and *KIF4B* (**C**) and their ancestral paralogs *PTTG1* (**A**), *MICB* (**B**), and *KIF4A* (**C**). The various zones of the fetal neocortical wall are indicated on the left and by red dashed lines. Green, yellow, and orange boxes indicate areas of the VZ, SVZ, and CP, respectively, that are shown at higher magnification in the respective images on the right. Scale bars in C apply to all panels and are 100 µm.](elife-32332-fig6){#fig6}

Cell type-specific expression patterns of the human-specific cNPC-enriched protein-coding genes compared to the corresponding ancestral paralogs {#s2-8}
------------------------------------------------------------------------------------------------------------------------------------------------

Complete or partial gene duplications often encompass the regulatory elements that control gene expression ([@bib7]; [@bib21]; [@bib29]; [@bib34]). This raises the question whether the human-specific cNPC-enriched protein-coding genes identified here exhibit similar cell-type expression patterns as their respective ancestral paralogs, or whether expression differences have evolved during human evolution.

Given that by ISH we could not distinguish the majority of the human-specific genes from their respective ancestral paralog, we sought an additional approach to gain insight into potential differences in expression between ancestral and human-specific paralogs. Specifically, we used our previously reported cell-type-specific RNA-Seq data from the human aRG population (aRG), the bRG population (bRG) and the neuron fraction (N) ([@bib25]) and re-analyzed these data using Kallisto. Kallisto is a probabilistic algorithm to estimate absolute transcript abundance, which has been proven to be accurate in assigning RNA-Seq reads to specific transcripts, including those originating from highly similar paralog genes ([@bib11]). We could confidently ascertain cell-type-specific mRNA expression profiles for 12 of the 15 human-specific genes and their corresponding ancestral paralog (Figure 7).

We first focused on changes in total mRNA levels between the human-specific genes and their ancestral paralogs. With the exception of *NOTCH2NL,* for which the total mRNA levels in aRG, bRG, and N were in the same range as the corresponding ancestral paralog, we found that the majority of the human-specific genes showed markedly different total mRNA expression levels compared to their ancestral paralog, which were either reduced (*ARHGAP11B*, *CBWD6*, *FAM72B/C/D*, *GTF2H2C*, *SMN2*) or increased (*ANKRD20A2*, *ANKRD20A4*, *DHRS4L2*, *ZNF492*) ([Figure 7B](#fig7){ref-type="fig"}). This reflects either changes in mRNA expression levels per cell, changes in the proportions of mRNA-expressing cells, or both. Irrespective of which is the case, this finding indicates that certain features of expression of these human-specific genes in the cNPC-to-neuron lineage might have changed compared to their ancestral paralogs during human evolution. This in turn raises the possibility that with the appearance of these human-specific genes their roles in the cell types concerned may have undergone some modification.

![Comparison of the mRNA expression of 12 human-specific cNPC-enriched protein-coding genes with their ancestral paralogs in isolated cell populations enriched in aRG, bRG and neurons from fetal human neocortex.\
A previously published genome-wide transcriptome dataset obtained by RNA-Seq of cell populations isolated from fetal human neocortex, that is, aRG (orange) and bRG (yellow) in S-G2-M and a fraction enriched in neurons but also containing bRG in G1 (N, purple) ([@bib25]), was analyzed for the abundance of mRNA-Seq reads assigned to either the indicated human-specific gene(s) under study (blue background) or the corresponding ancestral paralog (white background), using the Kallisto algorithm. (**A**) Min-max box-and-whiskers plots showing mRNA levels (expressed in Transcripts Per Million, TPM); red lines indicate the median. (**B**) Stacked bar plots showing the cumulative mRNA expression levels in the indicated cell types (sum of the median TPM values shown in (**A**)).\
10.7554/eLife.32332.021Figure 7---source data 1.Alignments of the mRNA sequences of ancestral and human-specific paralogs of the orthology groups ANKRD20A, ARHGAP11, CBWD, DHRS4, FAM72, GTF2H2, NOTCH2 and ZNF98.This zipped folder contains 8 files of alignments between the mRNA sequences of ancestral and human-specific paralogs of the orthology groups ANKRD20A, ARHGAP11, CBWD, DHRS4, FAM72, GTF2H2, NOTCH2 and ZNF98 that were used as a mapping reference to identify paralog-specific mRNA reads in the analysis performed in [Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}.](elife-32332-fig7){#fig7}

Next, we asked whether the human-specific genes diverged in their pattern of expression in aRG vs. bRG vs. N from that of their ancestral paralogs. For five of the human-specific genes (*CBWD6*, *FAM72B/C/D*, and *NOTCH2NL*), the pattern of mRNA levels in these three cell populations was similar to that of the respective ancestral paralog ([Figure 7A](#fig7){ref-type="fig"}). In the case of the other seven human-specific genes, we observed differences in the expression in aRG vs. bRG. For instance, *ZNF492* expression is lower in bRG than aRG, in contrast to what is observed for ancestral *ZNF98* expression. Vice versa, *ARHGAP11B*, *DHRS4L2*, *GTF2H2C*, and *SMN2* expression is higher in bRG than aRG, in contrast to what is observed for the respective ancestral paralog. Of note, the increase in the *ARHGAP11B* mRNA level in bRG as compared to aRG is consistent with the previously reported function of this gene in basal progenitor amplification ([@bib25]; [@bib26]). Moreover, we observed decreases (*ANKRD20A2*, *ANKRD20A4*) or increases (*DHRS4L2*, *GTF2H2C*) in the N fraction mRNA level, in relation to the aRG and bRG mRNA levels, compared to their respective ancestral paralog ([Figure 7A](#fig7){ref-type="fig"}). These findings suggest that these six human-specific genes underwent changes in regulatory elements at the transcriptional and/or post-transcriptional level.

We sought to corroborate these data by subjecting the previously prepared cDNAs of aRG, bRG, and N ([@bib25]) to qPCR analysis to quantify the transcripts of selected human-specific genes and their respective ancestral paralogs. We could design appropriate qPCR primers for four such pairs, *ARHGAP11B* vs. *ARHGAP11A*, *GTF2H2C* vs. *GTF2H2*, *NOTCH2NL* vs. *NOTCH2*, and *ZNF492* vs. *ZNF98*. As shown in [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}, this analysis largely confirmed the results of the Kallisto analysis ([Figure 7A](#fig7){ref-type="fig"}).

To complement these data, we performed a second type of analysis. We identified paralog-specific sequencing reads ([Figure 7---source data 1](#fig7sdata1){ref-type="supplementary-material"}; see [Figure 7---figure supplement 2A](#fig7s2){ref-type="fig"} for illustration of a hypothetical example) using our previously reported RNA-Seq dataset ([@bib25]), and then determined the number of paralog-specific sequencing reads for the 11 human-specific genes and their corresponding ancestral paralog in aRG, bRG, and N ([Figure 7---figure supplement 2B](#fig7s2){ref-type="fig"}). This analysis largely corroborated the results shown in [Figure 7A](#fig7){ref-type="fig"}, further pointing to expression changes in aRG vs. bRG vs. N for the human-specific genes in comparison to their corresponding ancestral paralogs.

We next ascertained expression of all human-specific genes identified in this study across all cell fractions (Florio, Johnson), single cells (Pollen) and cortical layers (Fietz, Miller) in the five gene sets analyzed ([Figure 7---figure supplements 3](#fig7s3){ref-type="fig"},[4](#fig7s4){ref-type="fig"}). Moreover, when this information was available, we determined expression of each gene in each individual fetal sample used to build these datasets ([Figure 7---figure supplements 3](#fig7s3){ref-type="fig"},[4C](#fig7s4){ref-type="fig"}), thus providing information about inter-individual variation. This analysis revealed good congruence between all gene sets ([Figure 7---figure supplements 3](#fig7s3){ref-type="fig"},[4](#fig7s4){ref-type="fig"}), and showed that virtually all genes analyzed were expressed in all individual specimens studied (with the exception of *NBPF10/14* in the Florio dataset, where these genes were not detected altogether; [Figure 7---figure supplement 3](#fig7s3){ref-type="fig"}).

In addition, since the Fietz dataset sampled six different fetal samples from four distinct gestational ages ([Figure 7---figure supplement 3](#fig7s3){ref-type="fig"}), we could investigate the temporal progression of expression of these genes during corticogenesis. While the majority of these genes show relatively constant or fluctuating gene expression levels across stages, some (*NOTCH2NL*, *FAM182B*) are enriched in the germinal zones at 13 wpc (early neurogenesis) compared to 14--16 wpc (mid-neurogenesis), while others (e.g. *FAM72C*, *FAM72D*) show the opposite expression pattern, suggesting that these genes may have differential roles during corticogenesis.

We finally explored the complexity in cell-type-specific expression patterns by examining the differential mRNA expression of protein-coding splice variants of the human-specific genes. Specifically, we analyzed our aRG vs. bRG vs. N RNA-Seq data ([@bib25]) for cell-type-specific gene expression and relative abundance of sequencing reads diagnostic of specific protein-coding splice variants of 14 of the 15 human-specific cNPC-enriched genes ([Figure 8](#fig8){ref-type="fig"}, [Supplementary file 4](#supp4){ref-type="supplementary-material"}). This showed, for most of these human-specific genes (*ANKRD20A2*, *ANKRD20A4*, *CBWD6*, *DHRS4L2*, *FAM72B/C*, *FAM182B*, *GTF2H2C*, *NBPF14*, *NOTCH2NL*, *SMN2*), the preferential expression of certain splice variants. Moreover, this analysis revealed splice variants with preferential expression in either aRG or bRG for some of these human-specific genes (e.g. *ARHGAP11B*, *CBWD6*, *GTF2H2C*, *SMN2*). A notable case was *ARHGAP11B*, of which one splice variant (Ensembl transcript ENST00000428041), endowed with a shorter 3\'-UTR, was exclusively expressed in bRG whereas the other splice variant (Ensembl transcript ENST00000622744) was enriched in aRG ([Figure 8](#fig8){ref-type="fig"}).

![Cell-type specificity of mRNA expression of splice variants encoded by 14 human-specific cNPC-enriched genes.\
Heatmaps showing TPM expression levels (see color keys on right) of all protein-coding splice variants encoded by the indicated 14 human-specific cNPC-enriched genes in aRG, bRG and neuron-enriched (N) cell populations from fetal human neocortex ([@bib25]). Only splice variants with detectable expression, albeit very low in some cases, are shown. *ZNF492* is not shown as only one splice variant exists. See [Supplementary file 4](#supp4){ref-type="supplementary-material"} for mRNA expression data for each cell type and splice variant, including non-coding transcripts. Human-specific genes are grouped based on orthology, and splice variants (indicated by Ensembl transcript IDs) encoded by the respective cNPC-enriched human-specific gene(s) are grouped together. Note that ENST00000428041, a splice variant of *ARHGAP11B* and ENST00000511812, a splice variant of *SMN2*, are uniquely expressed in bRG (red boxes). Splice variant-specific mRNA expression was assessed using the Kallisto algorithm.](elife-32332-fig8){#fig8}

In summary, these analyses show that after duplication, the expression pattern of most of the resulting new, human-specific cNPC-enriched protein-coding genes evolved differences in both the levels and cell-type specificity of their mRNAs compared to their respective ancestral paralog.

Human-specific *NOTCH2NL* promotes basal progenitor proliferation {#s2-9}
-----------------------------------------------------------------

To illustrate the value of our resource for studying potential roles of the human-specific cNPC-enriched genes in neocortical expansion, we focused on *NOTCH2NL*, as Notch signaling is known to be important for cNPC behavior ([@bib39]; [@bib57]; [@bib46]; [@bib35]; [@bib80]). The NOTCH2NL protein is equivalent to the NOTCH2 protein encoded by the shortest *NOTCH2* splice variant ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). To investigate a potential role of *NOTCH2NL* in cNPCs, we used in utero electroporation to express *NOTCH2NL* under the control of a constitutive promoter in neocortical aRG of embryonic day (E) 13.5 mouse embryos. Analysis of the progeny of the targeted aRG by immunofluorescence for PCNA and Ki67, two markers of cycling cells, 48 hr after *NOTCH2NL* electroporation revealed an increase in cycling basal progenitors in the SVZ and IZ, but not in apical progenitors in the VZ ([Figure 9A--D](#fig9){ref-type="fig"}). This increase involved bIPs expressing Tbr2 ([Figure 9F,G](#fig9){ref-type="fig"}), rather than bRG expressing Sox2 ([Figure 9H,I](#fig9){ref-type="fig"}). Concomitant with this increase, we observed a decrease in cell cycle exit in the SVZ, as indicated by the decrease in Ki67 expression in the progeny of BrdU-labeled cells derived from the targeted aRG ([Figure 9C,E](#fig9){ref-type="fig"}). These data were further corroborated by analysis of mitotic cNPCs using phosphohistone H3 immunofluorescence, which showed an increase in abventricular, but not ventricular, mitoses ([Figure 9J,K](#fig9){ref-type="fig"}). Thus, forced expression of the human-specific *NOTCH2NL* gene in mouse embryonic neocortex promotes basal progenitor proliferation.

![Forced expression of *NOTCH2NL* in mouse embryonic neocortex increases cycling basal progenitors.\
The neocortex of E13.5 mouse embryos was in utero co-electroporated with a plasmid encoding GFP together with either an empty vector (Control) or a *NOTCH2NL* expression plasmid (NOTCH2NL), all under constitutive promoters, followed by analysis 48 hr later. Bromodeoxyuridine (BrdU) was administered by intraperitoneal injection (10 mg/kg) into pregnant mice at E14.5 (**C, E**). (**A**) GFP (green) and PCNA (magenta) double immunofluorescence combined with DAPI staining (white) of control (left) and *NOTCH2NL*-electroporated (right) neocortex. (**B**) Quantification of the percentage of the progeny of the targeted cells, that is, the GFP+ cells, that are PCNA+ in the VZ, SVZ and IZ upon control (white columns) and *NOTCH2NL* (black columns) electroporation. (**C**) GFP (green), BrdU (yellow), and Ki67 (magenta) triple immunofluorescence combined with DAPI staining (white) of control (left) and *NOTCH2NL*-electroporated (right) neocortex. (**D**) Quantification of the percentage of the progeny of the targeted cells, that is, the GFP+ cells, that are Ki67+ in the VZ, SVZ, and IZ upon control (white columns) and *NOTCH2NL* (black columns) electroporation. (**E**) Quantification of the percentage of the BrdU-labeled progeny of the targeted cells, that is, the GFP+ cells, that are Ki67--, that is, that did not re-enter the cell cycle, in the VZ, SVZ, and IZ upon control (white columns) and *NOTCH2NL* (black columns) electroporation. (**F, H**) GFP (green), Ki67 (magenta), and either Tbr2 (**F**) or Sox2 (**H**) (yellow) triple immunofluorescence combined with DAPI staining (white) of control (left) and *NOTCH2NL*-electroporated (right) neocortex. (**G, I**) Quantification of the percentage of the progeny of the targeted cells, that is, the GFP+ cells, that are Ki67+ and Tbr2+ (**G**) or Ki67+ and Sox2+ (**I**) in the VZ, SVZ and IZ upon control (white columns) and *NOTCH2NL* (black columns) electroporation. (**J**) GFP (green) and phosphohistone H3 (PH3, magenta) double immunofluorescence of control (left) and *NOTCH2NL*-electroporated (right) neocortex. Yellow arrowheads, GFP-- and PH3+ abventricular cells. White arrowheads, GFP+ and PH3+ abventricular cells. (**K**) Quantification of the number of ventricular and abventricular progeny of the targeted cells, that is, the GFP+ cells, that are in mitosis (PH3+) in a 200 μm-wide microscopic field upon control (white columns) and *NOTCH2NL* (black columns) electroporation. (**A, C, F, H, J**) Images are single 2 μm optical sections. Scale bars, 50 μm. (**B, D, E, G, I, K**) Data are mean of 6--11 embryos each, averaging the numbers obtained from 1 to 4 cryosections per embryo (one 100 μm-wide (**B, D, E, G, I**) or 200 μm-wide (**K**) microscopic field per cryosection). Error bars indicate SEM; \*p\<0.05; \*\*p\<0.01;\*\*\*p\<0.001; Student's t-test.](elife-32332-fig9){#fig9}

Discussion {#s3}
==========

Our study not only provides a resource of genes that are promising candidates to exert specific roles in the development and evolution of the primate, and notably human, neocortex, but also has implications regarding (i) the emergence of these genes during primate evolution and (ii) the maintenance vs. modification of the cell-type specificity of their expression.

As to the emergence of these genes during primate evolution, two aspects of our findings deserve comment. First, different mechanisms contributed to the origin of human-specific cNPC-enriched protein-coding genes. While entire or partial gene duplications gave rise to the vast majority of these genes, consistent with previous results ([@bib7]; [@bib21]; [@bib29]; [@bib34]), we found that exon duplications can give rise to chimeric genes, as observed for *ZNF492*, and that the removal of a translational stop codon can create a new open reading frame, as observed for *FAM182B*. Among the primate- but not human-specific genes, two genes with functions that are likely relevant for cell proliferation (*KIF4B*, *PTTG2;* ([@bib12]; [@bib44]; [@bib49])) arose by retroposition of a reverse transcribed spliced mRNA, highlighting another mechanism for the emergence of new genes. Here, *PTTG2* is a particularly interesting case, since it was inactivated during the evolution of non-Hominoidea Simiiformes but remained intact during the evolution of Hominoidea. This raises the possibility that *PTTG2* may exert a role in the development of the neocortex of apes and human but not of New-World and Old-World monkeys. Given the expression of *PTTG2* in the germinal zones of fetal human neocortex and the fact that this gene is derived from *PTTG1*, which encodes a protein exhibiting tumorigenic activity ([@bib77]), it will be interesting to explore whether *PTTG2* may amplify cNPCs.

Second, of the 50 primate-specific human genes, 15 (30%) are human-specific and 17 (34%) arose in the Catarrhini ancestor. These percentages are higher than expected from a constant rate of gene emergence on the phylogenetic branches leading from the primate ancestor to human. Indeed, relating the number of new cNPC-enriched genes to the rate of neutral mutations revealed the two branches leading to Catarrhini (branch 6, [Figure 2A](#fig2){ref-type="fig"}) and to human (branch 1, [Figure 2A](#fig2){ref-type="fig"}), respectively, as outliers ([Figure 2B](#fig2){ref-type="fig"}). With regard to the branch leading to Catarrhini, one may speculate whether the increased appearance of new cNPC-enriched genes was related to the concomitant increase in gyrencephaly. With regard to the branch leading to human, one may speculate whether the increased appearance of new cNPC-enriched genes was related to the concomitant increase in brain size.

As to the issue of maintenance vs. modification of the cell-type specificity of expression of the human-specific genes, it is striking to observe that the majority of these genes, despite arising by entire or partial gene duplications, show marked differences not only in the level but also in the cNPC-type specificity of their mRNA expression compared to their ancestral paralog. For several of the human-specific genes, the corresponding spatial characteristics of their mRNA expression in the neocortical germinal zones and cNPC types could be corroborated by specific ISH and cell-type-specific RNA-Seq data, respectively. These data suggest that during human evolution, after gene duplication, these genes underwent specific changes in regulatory elements at the transcriptional and/or post-transcriptional level.

Our resource of primate-specific genes provides promising candidates that could have contributed to the evolution of primate-specific, including human-specific, features of neocortical development. Indeed, we found that expressing the human-specific cNPC-enriched gene *NOTCH2NL* in mouse embryonic neocortex increased the abundance of cycling basal progenitors, a hallmark of the developing human neocortex. The NOTCH2NL protein studied here is predicted to lack a signal peptide, which raises the issue of whether the NOTCH2NL protein is secreted, and if so, via which pathway, or whether the effect of *NOTCH2NL* in basal progenitors is due to the *NOTCH2NL* mRNA only or to an action of the NOTCH2NL protein in the cytoplasm.

Moreover, we previously showed that the human-specific function of *ARHGAP11B* in cNPCs arose by a single-nucleotide substitution that generated a new splice donor site, the use of which generates a novel human-specific C-terminal protein sequence that we implicate in basal progenitor amplification ([@bib25]; [@bib26]). Importantly, this single-nucleotide substitution presumably occurred relatively recently during human evolution ([@bib26]), that is, after the partial gene duplication event \~5 million years ago ([@bib63]; [@bib3]; [@bib18]). Furthermore, we have identified here an *ARHGAP11B* splice variant that is specifically expressed in human bRG ([Figure 8](#fig8){ref-type="fig"}), the basal progenitor type thought to have a key role in neocortex expansion ([@bib46]; [@bib9]; [@bib8]; [@bib10]; [@bib24]). Interestingly, in contrast to the other protein-coding *ARHGAP11B* splice variant detected, which contains a long 3\'-UTR with predicted microRNA binding sites and which is predominantly expressed in aRG, the bRG-specific *ARHGAP11B* splice variant contains only a short 3\'-UTR lacking predictable microRNA binding sites. This suggests that *ARHGAP11B* mRNAs may be subject to differential, microRNA-mediated, regulation depending on whether ARHGAP11B functions in the lineage progression from aRG to bRG or in bRG amplification. Taken together, our findings reveal genomic changes at a variety of levels that gave rise to novel functions and patterns of expression in cNPCs and that are likely relevant for the development and evolution of the human neocortex.

Materials and methods {#s4}
=====================

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\       Designation               Source or reference                                     Identifiers                                                          Additional information
  or resource                                                                                                                                                                          
  ----------------------------- ------------------------- ------------------------------------------------------- -------------------------------------------------------------------- ---------------------------
  Strain, strain\               C57BL/6J                  MPI-CBG Animal Facility                                                                                                      
  background (*Mus musculus*)                                                                                                                                                          

  Biological sample\            fetal neocortex\          Universitätsklinikum\                                                                                                        
  (*Homo sapiens*)              tissue (13 wpc)           Carl Gustav Carus Dresden                                                                                                    

  Antibody                      anti-BrdU (mouse)         MPI-CBG Antibody Facility                                                                                                    (1:1000)

  Antibody                      anti-GFP (chicken\        Abcam                                                   Abcam Cat\# ab13970,\                                                (1:1000)
                                polyclonal)                                                                       RRID:[AB_300798](https://scicrunch.org/resolver/AB_300798)           

  Antibody                      anti-PH3 (rat\            Abcam                                                   Abcam Cat\# ab10543,\                                                (1:1000)
                                monoclonal)                                                                       RRID:[AB_2295065](https://scicrunch.org/resolver/AB_2295065)         

  Antibody                      anti-Tbr2 (mouse)         MPI-CBG Antibody Facility                                                                                                    (1:500)

  Antibody                      anti-Sox2 (goat\          R + D Systems                                           R and D Systems Cat\#\                                               (1:500)
                                polyclonal)                                                                       AF2018, RRID:[AB_355110](https://scicrunch.org/resolver/AB_355110)   

  Antibody                      anti-Ki67 (rabbit\        Abcam                                                   Abcam Cat\# ab15580,\                                                (1:500)
                                polyclonal)                                                                       RRID:[AB_443209](https://scicrunch.org/resolver/AB_443209)           

  Antibody                      anti-PCNA (mouse\         Millipore                                               Millipore Cat\# CBL407,\                                             (1:500)
                                monoclonal)                                                                       RRID:[AB_93501](https://scicrunch.org/resolver/AB_93501)             

  Antibody                      Alexa Fluor 488-, 555-\   Molecular Probes                                                                                                             (1:500)
                                and 594-secondaries                                                                                                                                    

  Recombinant DNA reagent       pCAGGS                    doi: 10.1126/science.aaa1975                                                                                                 

  Recombinant DNA reagent       pCAGGS-GFP                doi: 10.1126/science.aaa1975                                                                                                 

  Recombinant DNA reagent       pCAGGS-NOTCH2NL           this paper                                                                                                                   *NOTCH2NL* was PCR\
                                                                                                                                                                                       amplified from cDNA and\
                                                                                                                                                                                       cloned into pCAGGS

  Sequence-based reagent        *ARHGAP11B* LNA probe     this paper                                                                                                                   AGTCTGGTACACGCCCTTCTTTTCT

  Sequence-based reagent        *DHRS4L2* LNA probe       this paper                                                                                                                   AGACAGTGGCGGTTGCGTGA

  Sequence-based reagent        *FAM182B* LNA probe       this paper                                                                                                                   GCAGGGATACACGGCTAT

  Sequence-based reagent        *GTF2H2C* LNA probe       this paper                                                                                                                   TCAGACGGCCTGCC

  Software, algorithm           cutadapt (v1.15)          <https://cutadapt.readthedocs.io/en/stable/>            RRID:[SCR_011841](https://scicrunch.org/resolver/SCR_011841)         

  Software, algorithm           STAR (v2.5.2b)            <https://github.com/alexdobin/STAR>                     RRID:[SCR_015899](https://scicrunch.org/resolver/SCR_015899)         

  Software, algorithm           Bedtools                  <http://bedtools.readthedocs.io/en/stable/#>            RRID:[SCR_006646](https://scicrunch.org/resolver/SCR_006646)         

  Software, algorithm           R                         The R Foundation                                                                                                             

  Software, algorithm           samtools                  Genome Research Limited                                 RRID:[SCR_002105](https://scicrunch.org/resolver/SCR_002105)         

  Software, algorithm           bowtie1                   <http://bowtie-bio.sourceforge.net/index.shtml>         RRID:[SCR_005476](https://scicrunch.org/resolver/SCR_005476)         

  Software, algorithm           BioMart                   Bioconductor                                                                                                                 

  Software, algorithm           BLAT                      <http://genome.ucsc.edu/cgi-bin/hgBlat?command=start>   RRID:[SCR_011919](https://scicrunch.org/resolver/SCR_011919)         

  Software, algorithm           Kallisto                  doi:10.1038/nbt.3519                                                                                                         

  Software, algorithm           FastQC                    Babraham Bioinformatics                                 RRID:[SCR_014583](https://scicrunch.org/resolver/SCR_014583)         

  Software, algorithm           dupRadar                  Bioconductor                                                                                                                 

  Software, algorithm           DESeq2                    Bioconductor                                            RRID:[SCR_015687](https://scicrunch.org/resolver/SCR_015687)         

  Software, algorithm           GeneTrail2                <https://genetrail2.bioinf.uni-sb.de>                                                                                        

  Other                         CESAR                     doi: 10.1093/nar/gkw210                                                                                                      
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Human fetal brain tissue {#s4-1}
------------------------

Human fetal brain tissue was obtained from the Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Carl Gustav Carus of the Technische Universität Dresden, following elective termination of pregnancy and informed written maternal consent, and with approval of the local University Hospital Ethical Review Committees. The gestational age of the specimen used for ISH (13 wpc) was assessed by ultrasound measurements of crown-rump length, as described previously ([@bib25]). Immediately after termination of pregnancy, the tissue was placed on ice and transported to the lab. The sample was then transferred to ice-cold Tyrode's solution, and tissue fragments of cerebral cortex were identified and dissected. Tissue was fixed in 4% paraformaldehyde in 120 mM phosphate buffer (pH 7.4) for 3 hr at room temperature followed by 24 hr at 4°C. Fixed tissue was then incubated in 30% sucrose overnight, embedded in Tissue-Tek OCT (Sakura, Netherlands), and frozen on dry ice. Cryosections of 12 µm were produced using a cryostat (Microm HM 560, Thermo Fisher Scientific) and stored at --20°C until processed for ISH.

Mice {#s4-2}
----

All animal experiments were performed in accordance with German animal welfare laws and overseen by the institutional review board. C57BL/6J mice were maintained in specific pathogen-free conditions in the MPI-CBG animal facility.

Identification of human cNPC-enriched protein-coding genes {#s4-3}
----------------------------------------------------------

To identify genes that are preferentially expressed in human cNPCs, five published transcriptome datasets ([@bib23]; [@bib25]; [@bib36]; [@bib51]; [@bib59]) were screened as described below; these transcriptome data had been generated from 13 to 21 wpc human fetal neocortex, using diverse cortical zone or cell-type-enrichment strategies and modes of determination of RNA levels (summarized in [Supplementary file 1](#supp1){ref-type="supplementary-material"}).

[@bib23] -- This transcriptome dataset ([@bib23]) was generated by RNA-Seq of the neocortical germinal zones (VZ, iSVZ, oSVZ) and CP isolated by LCM from the neocortex of 6 human fetuses ranging in gestational age from 13 to 16 wpc. The data were screened for protein-coding genes more highly expressed, across all stages, in either VZ, iSVZ, or oSVZ than CP (as determined by DGE analysis, p\<0.01 and FPKM≥1.5). The resulting gene set contained 2780 genes ([Supplementary file 1](#supp1){ref-type="supplementary-material"}, [Figure 1](#fig1){ref-type="fig"}).

[@bib51] (BrainSpan Atlas of the Allen Brain Institute, Prenatal LMD Microarray, <http://www.brainspan.org/lcm/search/index.html>) -- This transcriptome dataset ([@bib51]) was generated by microarray RNA expression profiling of germinal zones (VZ, iSVZ, oSVZ) and neuron-enriched layers (IZ, subplate, CP, marginal zone, subpial granular zone) isolated by LCM from fetal human neocortex. The data were screened for protein-coding genes with highest correlation with either VZ, iSVZ, or oSVZ (correlation coefficient \>0.25) compared to all neocortical regions analyzed. Correlation scores were taken from the original publication (see [Supplementary file 1](#supp1){ref-type="supplementary-material"}). For the purpose of this analysis, we paired together correlation scores from the two 15--16 wpc samples and the two 21 wpc samples originally included in the study. A gene was considered to be cNPC-enriched if it showed laminar correlation with either of the three germinal zones in both 15--16 wpc samples or in both 21 wpc samples. The resulting gene set contained 3802 genes ([Supplementary file 1](#supp1){ref-type="supplementary-material"}, [Figure 1](#fig1){ref-type="fig"}).

[@bib25] -- This transcriptome dataset ([@bib25]) was generated by RNA-Seq of human radial glia subtypes (aRG and bRG) and CP neurons (N) isolated from the neocortex of two 13 wpc human fetuses. These cell types were differentially labeled using a combination of fluorescent molecular markers, and isolated by FACS. By experimental design, only cells that exhibited apical plasma membrane and/or contacted the basal lamina were isolated. Moreover, the isolation of aRG and bRG was confined to cells that had duplicated their DNA, and the neuron fraction contained a minority of bRG in G1 ([@bib25]). The data were screened for protein-coding genes with higher expression in either aRG or bRG than N (as determined by DGE analysis, p\<0.01 and FPKM≥0.5). For this analysis, we used differential analysis data from the original publication (see [Supplementary file 1](#supp1){ref-type="supplementary-material"}). The resulting gene set contained 2030 genes ([Supplementary file 1](#supp1){ref-type="supplementary-material"}, [Figure 1](#fig1){ref-type="fig"}).

[@bib59] -- This transcriptome dataset ([@bib59]) was generated by RNA-Seq of single cells captured from the VZ and SVZ microdissected from the neocortex of three 16--18 wpc human fetuses. Cells were post-hoc attributed -- based on gene expression profiling -- to either radial glia (aRG and bRG), intermediate progenitors (i.e. bIPs), or neurons (N). The data were screened for genes positively correlated with either radial glia or bIPs (correlation coefficient \>0.1) and negatively correlated with N (correlation coefficient \<0.03). An expression cutoff was set to a minimum of 9 cells with detectable expression for a given gene (i.e. 2% of all sampled cells in the original study). Correlation scores were taken from the original publication (see [Supplementary file 1](#supp1){ref-type="supplementary-material"}). The resulting gene set contained 4391 genes ([Supplementary file 1](#supp1){ref-type="supplementary-material"}, [Figure 1](#fig1){ref-type="fig"}).

[@bib36] -- This transcriptome dataset ([@bib36]) was generated by RNA-Seq of human radial glia subtypes (aRG and bRG) and a population of intermediate progenitors and neurons isolated from the neocortex of one 18 wpc and two 19 wpc human fetuses. These cell types were differentially labeled using a combination of fluorescent molecular markers, and isolated by FACS. For the purpose of the present analysis, the original RNA-Seq data were re-processed as follows: sequencing reads were checked for overall quality using FastQC (v0.11.2). Read alignments were performed using human genome reference assembly GRCh38 and quantification of genes of Ensembl release v88 was done using STAR (v2.5.2b). Duplicated reads were identified using Picard MarkDuplicates (v2.10.2) and were analyzed with dupRadar (v1.6.0). Differential gene expression analysis on raw counts was performed with DESeq2 (v1.16.1). Data were screened for protein-coding genes with higher expression in aRG and/or bRG as compared to the cell population enriched in intermediate progenitors and neurons (as determined by DGE analysis, p\<0.01 and FPKM≥0.1). The resulting gene set contained 1617 genes ([Supplementary file 1](#supp1){ref-type="supplementary-material"}, [Figure 1](#fig1){ref-type="fig"}).

The gene sets resulting from these analyses contain only protein-coding genes, which were identified and selected using the Ensembl data-mining tool BioMart (<http://www.ensembl.org/biomart/martview/>), implementing the Genome Reference Consortium Human Build 38 (GRCh38.p10) dataset.

Next, the five gene sets obtained were intersected. To do this, all gene IDs contained in the five original transcriptome datasets were converted to match the latest Ensembl gene annotation (Ensembl v89) of the GRCh38.p10 genome assembly. The five gene sets obtained were then searched for the co-occurrence of genes (or lack thereof). This resulted in 3458 human cNPC-enriched protein-coding genes present in at least two of the five gene sets (listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}, see also [Figure 1](#fig1){ref-type="fig"}).

Gene ontology (GO) term enrichment analysis {#s4-4}
-------------------------------------------

GO term enrichment analysis was performed using GeneTrail2 (<https://genetrail2.bioinf.uni-sb.de/>) using the 3458 human cNPC-enriched protein-coding genes as input. We performed over-representation analysis as set-level statistic, using the Benjamini-Yekutieli false discovery method to adjust p-values, a significance threshold of 0.05. Raw output of this analysis is shown in [Supplementary file 2](#supp2){ref-type="supplementary-material"}.

Screening of human cNPC-enriched protein-coding genes for primate-specific orthologs {#s4-5}
------------------------------------------------------------------------------------

The 3458 human cNPC-enriched protein-coding genes were screened for the occurrence of one-to-one orthologs in non-primate species, using BioMart and implementing v89 Ensembl annotation of '1-to-1 orthologs'. All genes that had an annotated one-to-one ortholog in non-primate species were excluded from the list of the 3458 human genes. This yielded 77 genes that were candidates to be primate-specific.

Whole genome alignments were visualized in the UCSC genome browser ([@bib74]) to manually analyze each of the 77 candidate primate-specific genes. To this end, co-linear chains of local alignments ([@bib40]) between the human hg38 genome assembly and the assemblies of non-primate mammals were inspected to check if the human gene locus aligned to non-primate mammals. For the genes that aligned to non-primate mammals, regardless of whether they aligned in a conserved or in a different context, gene annotations of the aligning species were used to assess which gene is annotated in the respective locus. For this purpose, gene annotations from Refseq, Ensembl ([@bib1]) and CESAR ([@bib66]) (a method that transfers human gene annotations to other aligned genomes if the gene has an intact reading frame) were used, and those candidate genes that likely have an aligning gene in non-primate mammals were removed. This reduced the list of the 77 candidates to 50 genes that were considered as primate-specific.

Tracing the evolution of the primate-specific genes in the primate lineage {#s4-6}
--------------------------------------------------------------------------

The evolution of these 50 primate-specific genes was traced in the primate lineage to determine which of these have orthologs, in non-human primates, to the corresponding 50 human cNPC-enriched protein-coding genes, and which do not, and therefore are human-specific. To this end, co-linear alignment chains and a multiple genome alignment that includes 17 non-human primate genomes ([@bib67]) were inspected. For the genes that aligned to other primates, the CESAR annotations were used to check if a gene of interest has an intact reading frame in other species. A gene was considered to be conserved only if an intact reading frame is present in the respective species. For example, while *FAM182B* aligns in a conserved context to chimpanzee and gorilla, CESAR did not find an intact reading frame and did not annotate the gene; indeed, inspecting the multiple genome alignment revealed a frameshift in chimpanzee and a stop codon mutation in gorilla, showing that *FAM182B* is likely a non-coding gene in non-human primates. Then, each gene was assigned to a node in the primate phylogeny (clade), based on the descending species that likely have an intact coding gene. Note that this inferred ancestry does not imply that all descending species have an intact gene. This is exemplified by *TMEM99*, which aligns to all great apes and has an intact reading frame in human and orangutan, but encodes no or a truncated protein in chimpanzee/bonobo (due to a frameshift mutation) and gorilla (due to a stop codon mutation).

This analysis was combined with BLAT searches using the human protein or human mRNA sequence to assess the number of aligning loci in other primates; however, this was not conclusive for highly complex loci such as the duplications involving *ANKRD20A* and *CBWD* genes, where numerous similar genes and pseudogenes are present and the completeness of non-human primate genome assemblies is not certain due to the presence of assembly gaps. In addition, for human-specific candidates that arose by duplication, inspecting the respective genomic locus in the chimpanzee genome browser was useful, since human duplications are visible as additional, overlapping alignment chains.

Paralog-specific and isoform-specific gene expression {#s4-7}
-----------------------------------------------------

To estimate expression differences among cNPC types between (a) given human-specific gene(s) and its/their highly similar ancestral paralog(s) in the human genome, the Kallisto probabilistic algorithm was used, which has been proven to be accurate in assigning reads to specific transcripts, including those originating from highly similar paralog genes in the human genome ([@bib11]).

For this analysis, reads generated previously by RNA-Seq of human aRG, bRG and N (SRA Access, SRP052294, ([@bib25])) were used as input, GRCh38 as genome reference, and Ensembl v89 as genome annotation reference. Transcript abundances were output in Transcripts per Million (TPM) units. To compare expression between human-specific and ancestral paralog genes ([Figure 7](#fig7){ref-type="fig"}), TPM values were extracted for all paralogs in each orthologous group, and the TPM values were summed for all protein-coding transcripts (as per Ensembl annotation) for each gene. To compare expression between different splice variants produced by each human-specific gene ([Figure 8](#fig8){ref-type="fig"}), the TPM values specific for each individual splice variant were extracted and the data were expressed relative to each other.

Kallisto's transcript abundance measurements represent a probabilistic approximation of actual transcript levels, and thus are an estimate. In order to compare actual paralog gene expression in distinct cNPC types and neurons, a second type of analysis was performed, which did not aim at providing an estimate of absolute transcript abundances, but rather at providing a precise determination of the relative gene expression differences between paralogs. To this end, mRNA sequences of ancestral and human-specific paralogs in each orthology group were aligned, using Clustalw2 (<http://www.ebi.ac.uk/Tools/msa/clustalw2/>), and the homologous (but not identical) core sequence of each alignment was identified manually ([Figure 7---source data 1](#fig7sdata1){ref-type="supplementary-material"}; see [Figure 7---figure supplement 2A](#fig7s2){ref-type="fig"} for illustration of a hypothetical example). The corresponding sequences of each paralog -- of same length by design -- were used as reference for previously generated RNA-Seq reads from aRG, bRG, and N (SRA Access, SRP052294, ([@bib25])) in order to search for paralog-specific mRNA reads. Reads aligning to both, ancestral and human-specific paralogs, were discarded as ambiguous, and only those reads aligning to paralog-specific sites (SNPs or indels), referred to as paralog-specific reads, were used for quantification ([Figure 7---figure supplement 2B](#fig7s2){ref-type="fig"}). This stringent alignment was carried out using bowtie1 (bowtie -Sp 5 -m 1 v0).

It should be noted that, in contrast to the Kallisto-based analysis, the latter type of analysis does not distinguish between reads that originate from protein-coding and non-protein-coding transcripts of a given gene. Therefore, the quantifications shown in [Figure 7---figure supplement 2B](#fig7s2){ref-type="fig"} reflect counts of all reads mapping to a given gene, whereas the quantifications shown in [Figure 7](#fig7){ref-type="fig"} reflect summed counts of protein-coding gene transcripts only.

qPCR validation of the paralog-specific gene expression analysis {#s4-8}
----------------------------------------------------------------

Neocortex of three 12--13 wpc human fetuses, obtained as described above, was used. The isolation of aRG and bRG in S-G2-M and of a fraction enriched in neurons but also containing bRG in G1 from fetal human neocortex, and the preparation of cDNA from these cell populations has already been described ([@bib25]). The cDNA libraries obtained from these FACS-isolated fractions were re-analyzed by qPCR, performed as previously described ([@bib25]; [@bib2]). Primer sequences are provided in [Supplementary file 5](#supp5){ref-type="supplementary-material"}. The qPCR data obtained were normalized to expression of *GAPDH*, as described previously ([@bib25]; [@bib2]).

Genomic qPCR {#s4-9}
------------

Genomic DNA was obtained from EBV-transformed B cells of human, bonobo and chimpanzee, as described previously ([@bib60]). Primers ([Supplementary file 6](#supp6){ref-type="supplementary-material"}) were designed for two different amplicons per orthologous gene group to bind to the same region of the human-specific gene(s) under study, its human paralog(s), and the chimpanzee and bonobo orthologs. Only one mismatch in the primer binding sequence between the reference genomes of the three species was allowed.

qPCR was performed on human, chimpanzee and bonobo genomic DNA, using either the ABsolute qPCR SYBR Greenmix (Thermo Fisher Scientific) on a Mx3000P qPCR System (Stratagene) or the Fast Start Essential DNA Green Master (Roche) on a Lightcycler 96 (Roche). The relative copy number between the three species was determined by the comparative cycle threshold (Ct) approach ([@bib43]) as follows. The Ct values for the human, chimpanzee and bonobo genes under study were normalized to the Ct value of the highly conserved single-copy gene *STX12*. The normalized values were then compared between the three species, using bonobo as reference, to determine the relative copy number.

Sequencing of genomic PCR products {#s4-10}
----------------------------------

PCR was performed on human, chimpanzee and bonobo genomic DNA using the REDTaq DNA polymerase (Sigma). Identical cycling and temperature conditions as used for the genomic qPCR described above (annealing at 60°C, 30 cycles) were applied. Input was 15 ng gDNA per 50 µl PCR reaction. Amplicons were checked on 3% agarose gels for the specificity of the PCR reaction; all PCR reactions yielded only one specific band of the correct size. For deep sequencing, amplicons were quantified and pooled at equal molarity such that (i) each pool was specific for one of the three species, and (ii) amplicons targeting an identical locus were distributed into two different pools (see [Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}).

Six barcoded Illumina libraries were generated by ligation of the Illumina-specific sequencing adaptors. Illumina sequencing of these libraries was performed on the MiSEQ device, sequencing regime was 2 × 150 bp.

Paired-end data (for raw data, please see [Figure 4---source datas 1](#fig4sdata1){ref-type="supplementary-material"}--[3](#fig4sdata3){ref-type="supplementary-material"}) were trimmed using cutadapt (v1.15; -m 20 -q 25 -a file:\${Ill_ADAPTERS} -A file:\${Ill_ADAPTERS}) and mapped with STAR (v2.5.2b; ---alignSJoverhangMin 100 ---outFilterType BySJout ---sjdbGTFfile \${gtfFile}). Bedtools intersect (v2.25.0) was used to determine the number of overlapping alignments at each locus of interest, and samtools flagstat was used to determine the library size. Final data integration and visualization was implemented using R. The analysis scripts can be found in the repository <https://git.mpi-cbg.de/scicomp/Florio_et_al_2018_Validation_of_genomic_qPCR_data.>

*NOTCH2NL* expression in mouse embryonic neocortex {#s4-11}
--------------------------------------------------

In utero electroporation (30 V, six 50-msec pulses with 1 s intervals) of E13.5 mouse embryos was performed on C57BL/6J mice as described previously ([@bib25]), using either 1 µg/µl of pCAGGS-NOTCH2NL and 0.5 µg/µl of pCAGGS-GFP or 1 µg/µl of empty pCAGGS and 0.5 µg/µl of pCAGGS-GFP in PBS containing 0.1% Fast Green. Electroporated neocortex was analyzed at E15.5 following 4% paraformaldehyde fixation ([@bib25]). Bromodeoxyuridine (BrdU) was administered by intraperitoneal injection (10 mg/kg) into pregnant mice at E14.5.

Immunofluorescence {#s4-12}
------------------

Immunofluorescence was performed on 20 µm cryosections as described previously ([@bib25]). The following primary antibodies were used: PCNA, mouse, Millipore, CBL407, 1/500; Ki67, rabbit, Abcam, Ab15580, 1/500; Sox2, goat, R + D Systems, AF2018, 1/500; Tbr2, mouse, MPI-CBG Antibody Facility, 1/500; PH3, rat, Abcam, Ab10543, 1/1000; GFP, chicken, Abcam, Ab13970, 1/1000. For BrdU immunofluorescence, cryosections were quenched for 15 min in 0.1 M glycine in PBS, incubated for 45 min in 2N HCl at 37°C, blocked in 10% horse serum in PBS, and then incubated with a conjugated fluorescent BrdU antibody (mouse, MPI-CBG Antibody Facility, 1/500) for 2 hr at room temperature. The following secondary antibodies were used: Alexa Fluor 488, 555, and 594, Molecular Probes, 1/500.

In-situ hybridization {#s4-13}
---------------------

Templates were amplified by PCR (see [Supplementary file 7](#supp7){ref-type="supplementary-material"} for primer sequences) from oligo-dT-primed cDNA prepared from fetal human neocortex total RNA, and RNA probes directed against the mRNA(s) of a given human-specific gene and (if applicable) its paralog(s) in the human genome were synthesized using the DIG RNA labeling Mix (Roche). The *ARHGAP11B* LNA probe was designed with the Custom LNA mRNA Detection Probe design tool (QIAGEN), focusing only on the sequence spanning the *ARHGAP11B* exon5--exon6 boundary, where *ARHGAP11B* is sufficiently different from *ARHGAP11A* (see [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}) ([@bib26]), and searching for hybridization with a predicted RNA melting temperature of 85°C. The LNA probe (5\'-AGTCTGGTACACGCCCTTCTTTTCT-3\') was synthesized and labeled with digoxigenin at the 5' and 3' ends (QIAGEN). Using the same melting temperature settings, the LNA probes for *GTF2H2C* (5\'-TCAGACGGCCTGCC-3\'), *FAM182B* (5\'-GCAGGGATACACGGCTAT-3\') and *DHRS4L2* (5\'-AGACAGTGGCGGTTGCGTGA-3\') were designed accordingly to target unique sequences of the respective transcripts.

In-situ hybridization was performed on 12--µm cryosections of 13 wpc fetal human neocortex and on COS-7 cells. Prior to the hybridization step, cryosections/cells were sequentially treated with 0.2 M HCl (2 × 5 min, room temperature) and then with 6 µg/ml proteinase K in PBS, pH 7.4 (20 min, room temperature). Hybridization was performed overnight at 65°C with either 20 ng/µl of a given RNA probe or 40 nM LNA probe. TSA Plus DIG detection Kit (Perkin Elmer) was used for signal amplification, and the signal was detected immunohistochemically with mouse anti-digoxigenin HRP antibody (Perkin Elmer) and NBT/BCIP (Roche) as color substrate.

Image acquisition {#s4-14}
-----------------

ISH images were acquired on a Zeiss Axio Scan slide scanner, and processed using ImageJ. Fluorescent images of electroporated neocortex were acquired using a Zeiss laser scanning confocal microscope 700 using a 20x objective. Quantifications were performed using Fiji.
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###### cNPC-enriched genes.

This file summarizes information of the five datasets, occurrence of all cNPC-enriched genes in the five datasets and composition of the five gene sets including gene expression data.

10.7554/eLife.32332.025

###### GO term analysis of cNPC-enriched genes.

This file contains the output of the GO term analysis.
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###### Chromosome location of all cNPC-enriched primate-specific genes in the different primates.

This file contains the chromosome location of all cNPC-enriched primate-specific genes in the 12 primate species analyzed.
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###### mRNA expression data of splice variants.

This file contains mRNA expression data for the human-specific genes and their corresponding ancestral paralog for each cell type and splice variant, including non-coding transcripts.

10.7554/eLife.32332.028

###### qPCR primer.

This file contains the primer sequences of the qPCR for the validation of the paralog-specific gene expression analysis.
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###### Primer for genomic qPCR.

This file contains the primer sequences of the genomic qPCR.
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###### Primer for ISH probes.

This file contains the primer sequences used to generate the templates for the synthesis of the ISH probes.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Evolution and cell-type specificity of human-specific genes preferentially expressed in progenitors of fetal neocortex\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Didier Stainier as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted these comments to help you consider how to proceed. While the reviews were favorable in general, and felt that the topic was important, there were concerns about the reliability of both the computational as well as the experimental data, which dampened their enthusiasm. As you can see from the critiques below, the issues can be divided into three categories: 1\] Applying more rigorous statistical analysis of the list of genes that are human- or primate-specific, to ensure that the list is both comprehensive and reliable. 2\] Re-analysis of the in situ hybridization data to ensure that the probes being used are specific for the transcript(s) of interest. 3\] Re-analysis of the in utero electroporation with additional controls to ensure that potential off-target effects are taken into account. Due to the number of these criticisms, *eLife* would understand if you decided to move the manuscript to another journal, to avoid lengthy revisions. But performing these revisions to the level to satisfy reviewers might be relatively straightforward for you, because these might be issues that you have previously addressed or can address in a straightforward way or with more detailed explanations of your methodology. We are interested in seeing this work published in *eLife*, and would like to put this question to you, and hear your preference for how to proceed.

Summary:

Florio et al. describe their efforts to mine existing transcriptomic data sets for genes that may have importance for human neurodevelopment. Building on their experience with the human-specific *ARHGAP11B*, they focused on genes that are either human- or primate-specific, with a strong focus on the former. They identified several such genes and characterized them by a combination of detailed expression analysis using the existing data, novel in situ hybridization approaches, as well as functional overexpression in the mouse cortex for one of the genes. They also provide analysis of the origin and evolutionary history of these genes.

This manuscript presents a laudable effort to combine the various transcriptome data sets that exist in this field and were generated by several labs. This allows to overcome limitations of the individual studies and to provide a more definitive answer to \'what are the defining genetic features of human brain development?\" Even as a candidate for a \'Tools and Resources\' contribution, there was a sense that the analysis was too preliminary for general conclusions.

Essential revisions:

1\) Almost all of their in situ hybridization experiments are unable to distinguish between the ancestral paralogs and the genes of interest due to probe cross-reaction, and in those cases where they do, the original gene is not shown. Could this problem not be circumvented using alternative RNA detection methods such as RNAscope or using LNAs (as done for one of the genes)? Given the lack of ability to distinguish between paralogs, the claim that one can distinguish gene expression patterns is quite bold. As it stands, very little can be deduced from these data, unless gene-specific ISH can be performed.

2\) The authors do not attempt any other cross-validation of the results presented in Figure 7 (which does not include all genes they describe) with qPCR, ddPCR, with or without a TaqMan strategy, or alternative method. Without this data, it is hard to accept the claims. In my opinion, there should be some independent way to validate this, especially if the authors want to draw such attention to their finding.

3\) Their selection of data sets omits the prominent example published by Johnson et al., 2015. While the authors might have reasons to exclude these data, this could be a very powerful data set as it is technically more similar to the Florio et al. data set than some of the others used.

4\) 3722 genes is a large proportion of the known genes, therefore any of these might be just found by coincidence. An enrichment analysis would useful to support the authors\' claim that there is indeed an enrichment for cell types and functions that one would expect based on their approach. As a side note, this section might also be improved by giving more concrete references for the markers, so the reader does not have to accept this statement at face value.

5\) The authors only functionally test one of the genes, which will leave readers wondering why others were not tested. What criteria did the authors use for choosing the specific genes to study molecular mechanisms of evolution?

The *NOTCH2NL* gene is a very interesting human-specific gene, as described in the analysis. However, the experiments in Figure 9 require more controls to justify the strong interpretation presented here, i.e. control that expresses the original *NOTCH2* to determine differences and similarities. While interesting, the experiments add little to the resource value of the paper and ought to be either strengthened or removed.

6\) In the third paragraph of the subsection "Spatial mRNA expression analysis in fetal human neocortex of the human-specific cNPC-enriched protein-coding genes and of three selected primate- but not human-specific protein-coding genes", the authors argue that those genes displaying the ISH expression pattern VZ,CP\>SVZ (high in both VZ and CP, while lower in SVZ) still fulfill the initial screening criterion of genes highly enriched in germinal zones. Their argument is that, for these genes, the sum of mRNA levels by RNAseq in the three germinal zones is greater than in CP. This argument is flawed because, to make this comparison, RNAseq data values should be averaged proportionally to cell density, which in any case the result would never be greater than the value observed in the individual layer with highest amount.

7\) In utero electroporations are frequently subject to artifact. In situ validation that the cells in the *NOTCH2NL* electroporated samples showing ectopic cycling and abventricular localization actually express *NOTCH2NL* should be presented. This is particularly important in light of the small number of abventricular cells in panel S1E.

8\) The differential gene expression strategy seems reasonable, but many times p-value does not capture the complexity of the different aspects of differential expression. Including a table with details about fold change, percent of cells expressing, and p-value for each dataset would be valuable for individuals who may have additional considerations than those presented in the paper, but precludes the need to repeat all the analysis. As such, including p-values up to 0.05 or even a bit higher would be most valuable, and the authors should highlight which genes were selected from each dataset for their analysis.

9\) None of the papers from which data was analyzed carefully considered the implication of number of individuals on analysis -- particularly for the single cell datasets, but also for the bulk analyses. It would be helpful to summarize for at least their top candidates in how many individuals the pattern was consistent with the overall significant observation (across datasets), and in how many the enrichment was non-existent or opposite. If any of the genes do not hold up in this analysis, they should be removed from the main figure gene lists.

10\) The analysis of genomic remodeling during human evolution is nice, but readers will wonder how frequently did one or other type of event take place? Given that the authors discovered not so many genes newly evolved in human or hominids, it is essential to perform similar analyses on a few more genes to provide a global view of which events of genetic evolution occurred more frequently, and even venture to speculate why some events occurred more frequently than others.

11\) Figure S1 -- Bottom panels for PH3 analysis at E14.5 after electroporation 1 day before: the graph and pictures show near-null presence of basal (abventricular) mitoses in control embryos, which is clearly not the case under normal circumstances, especially at this intermediate stage of cortical neurogenesis. How is this possible, even in GFP- cells?

10.7554/eLife.32332.045

Author response

> Essential revisions:
>
> 1\) Almost all of their in situ hybridization experiments are unable to distinguish between the ancestral paralogs and the genes of interest due to probe cross-reaction, and in those cases where they do, the original gene is not shown. Could this problem not be circumvented using alternative RNA detection methods such as RNAscope or using LNAs (as done for one of the genes)? Given the lack of ability to distinguish between paralogs, the claim that one can distinguish gene expression patterns is quite bold. As it stands, very little can be deduced from these data, unless gene-specific ISH can be performed.

As requested, we have now used specific probes for those human-specific genes for which the mRNA nucleotide sequence is sufficiently different to the respective ancestral paralog to design such probes. This was the case for *ARHGAP11B, NOTCH2NL, DHRS4L2, FAM182B, GTF2H2C* and *ZNF492*. In addition, we designed probes that selectively target the ancestral paralogs, wherever possible, to allow comparison with the cellular distribution of the mRNA of the respective human-specific gene. This was the case for *ARHGAP11A* and *NOTCH2*. These new results are described in the main text and in Figure 5. For *ANKRD20A2/4* vs. *ANKRD20A1, CBWD6* vs. *CBWD1, FAM72B/C/D* vs. *FAM72A*, and *SMN2* vs. *SMN1*, the nucleotide differences are simply too small and therefore it is not possible to design specific probes that selective target the mRNAs of these genes only. Therefore, we present the results of probes that target these paralog families.

> 2\) The authors do not attempt any other cross-validation of the results presented in Figure 7 (which does not include all genes they describe) with qPCR, ddPCR, with or without a TaqMan strategy, or alternative method. Without this data, it is hard to accept the claims. In my opinion, there should be some independent way to validate this, especially if the authors want to draw such attention to their finding.

As requested by the reviewers, we have sought to validate by qPCR the differential expression between ancestral vs. human-specific paralogs originally presented in Figure 7. We were able to design primers detecting specific expression of ancestral vs. human-specific paralog pairs in the case of *ARHGAP11A/B, GTF2H2/GTF2H2C, NOTCH2/NOTCH2NL* and *ZNF98/ZNF492*, and we performed a qPCR analysis using cDNA libraries previously prepared from pools of cNPCs and neurons, FACSisolated from fetal human neocortex (Florio et al., 2015) -- thus validating our data in the same cell populations analyzed in Figure 7. We were also able to independently detect *SMN1/2* in our Kallisto data re-analysis of the Florio 2015 dataset, thus extending our previous analysis to 12 of the 14 human-specific gene duplications contained in our list.

> 3\) Their selection of data sets omits the prominent example published by Johnson et al., 2015. While the authors might have reasons to exclude these data, this could be a very powerful data set as it is technically more similar to the Florio et al. data set than some of the others used.

We would like to thank the reviewers for this important suggestion. We have now included the Johnson et al., 2015 transcriptome dataset in our analysis and performed a comprehensive re-analysis of the combined 5 datasets. Our re-analysis, described in the updated Figures 1 and 2, yielded 3,458 human cNPC-enriched protein-coding genes, 50 of which are primate-specific. While most of the genes reported in the original submission are still included in our new gene set, this analysis allowed us to identify two additional human-specific genes (*NBPF10, NBPF14*) and four additional primate-specific genes (*GLUD2, MT1M, SLFN13, ZNF730*).

> 4\) 3722 genes is a large proportion of the known genes, therefore any of these might be just found by coincidence. An enrichment analysis would useful to support the authors\' claim that there is indeed an enrichment for cell types and functions that one would expect based on their approach. As a side note, this section might also be improved by giving more concrete references for the markers, so the reader does not have to accept this statement at face value.

As requested by the reviewers, we have performed a GO term and pathway enrichment analysis using the final set of the 3,458 human cNPC-enriched genes as input. Despite its large size, this gene set is highly enriched in terms and pathways related to cell cycle, especially mitotic cell division. Top-enriched GO terms in the categories of biological process and cellular component are shown in the new Figure 1F, and the output of the analysis is shown in Supplementary file 2.

Further, addressing the reviewers' concern, we have added references to original papers and reviews discussing the significance of the cNPC marker genes contained in our gene set, and highlighted this in the Results section.

> 5\) The authors only functionally test one of the genes, which will leave readers wondering why others were not tested. What criteria did the authors use for choosing the specific genes to study molecular mechanisms of evolution?
>
> The NOTCH2NL gene is a very interesting human-specific gene, as described in the analysis. However, the experiments in Figure 9 require more controls to justify the strong interpretation presented here, i.e. control that expresses the original NOTCH2 to determine differences and similarities. While interesting, the experiments add little to the resource value of the paper and ought to be either strengthened or removed.

We selected *NOTCH2NL* in light of the pivotal role played by Notch signaling in cNPC proliferation and lineage progression, which made *NOTCH2NL* stand out as a remarkably promising candidate to exert a role in corticogenesis. This has now been clarified better in the main text.

In line with the request of the reviewers, we have now performed several additional experiments to strengthen the validity of our *NOTCH2NL* results. We believe that the data provided now conclusively show that expression of the human-specific gene *NOTCH2NL* in mouse embryonic neocortex is sufficient to expand the pool of basal progenitors. Specifically, we have performed immunofluorescence for PCNA as an additional marker of cycling cells, thus confirming our previous data obtained by Ki67 immunostaining. Furthermore, by immunofluorescence for Tbr2 and Sox2 we could show that the increase in cycling basal progenitors is due to an increase in cycling bIPs (Tbr2-positive) rather than in cycling bRG (Sox2-positive). Finally, by determining the rate of cell cycle exit in the SVZ by Ki67 and BrdU immunofluorescence staining, we observed a decrease in cell cycle exit, thus confirming an increase in cycling cells. These new data are shown in the new main Figure 9 and are described in the last section of Results.

> 6\) In the third paragraph of the subsection "Spatial mRNA expression analysis in fetal human neocortex of the human-specific cNPC-enriched protein-coding genes and of three selected primate- but not human-specific protein-coding genes", the authors argue that those genes displaying the ISH expression pattern VZ,CP\>SVZ (high in both VZ and CP, while lower in SVZ) still fulfill the initial screening criterion of genes highly enriched in germinal zones. Their argument is that, for these genes, the sum of mRNA levels by RNAseq in the three germinal zones is greater than in CP. This argument is flawed because, to make this comparison, RNAseq data values should be averaged proportionally to cell density, which in any case the result would never be greater than the value observed in the individual layer with highest amount.

In line with the reviewers\' comment, we have deleted this paragraph.

> 7\) In utero electroporations are frequently subject to artifact. In situ validation that the cells in the NOTCH2NL electroporated samples showing ectopic cycling and abventricular localization actually express NOTCH2NL should be presented. This is particularly important in light of the small number of abventricular cells in panel S1E.

As requested by the reviewer, we have electroporated an HA-tagged version of *NOTCH2NL*. [Author response image 1](#respfig1){ref-type="fig"} shows high magnification images of electroporated cells in the SVZ of two independent samples. *NOTCH2NL* expression was detected by an anti-HA antibody. Abventricular cells are clearly HA-positive and show a strong correlation with GFP-expressing cells, indicating that abventricular cells express NOTCH2NL after electroporation.

![](elife-32332-resp-fig1){#respfig1}

> 8\) The differential gene expression strategy seems reasonable, but many times p-value does not capture the complexity of the different aspects of differential expression. Including a table with details about fold change, percent of cells expressing, and p-value for each dataset would be valuable for individuals who may have additional considerations than those presented in the paper, but precludes the need to repeat all the analysis. As such, including p-values up to 0.05 or even a bit higher would be most valuable, and the authors should highlight which genes were selected from each dataset for their analysis.

As requested by the reviewers, we have now expanded our Supplementary file 1 to show the expression levels, differential expression values and/or correlation scores of all genes in all five gene sets. Comparison of these five lists of genes with the list of the 3,458 cNPC-enriched genes allows the identification of the genes selected from each gene set.

> 9\) None of the papers from which data was analyzed carefully considered the implication of number of individuals on analysis -- particularly for the single cell datasets, but also for the bulk analyses. It would be helpful to summarize for at least their top candidates in how many individuals the pattern was consistent with the overall significant observation (across datasets), and in how many the enrichment was non-existent or opposite. If any of the genes do not hold up in this analysis, they should be removed from the main figure gene lists.

We would like thank the reviewers for raising this important point. We have added two supplementary figures (Figure 7---figure supplement 3 and 4) showing gene expression profiles of all the cNPC-enriched human-specific genes, in all datasets analyzed, across all samples and individuals. This analysis showed that virtually all genes analyzed were expressed in all individual specimens studied (with the exception of *NBPF10/14* in the Florio dataset, where these genes were not detected altogether; Figure 7---figure supplement 3). Moreover, since the Fietz dataset sampled six different fetal samples from four distinct gestational ages (13-16 wpc), we could provide information on the temporal progression of expression of these genes during corticogenesis (Figure 7---figure supplement 3).

> 10\) The analysis of genomic remodeling during human evolution is nice, but readers will wonder how frequently did one or other type of event take place? Given that the authors discovered not so many genes newly evolved in human or hominids, it is essential to perform similar analyses on a few more genes to provide a global view of which events of genetic evolution occurred more frequently, and even venture to speculate why some events occurred more frequently than others.

We have repeated our previous analysis on the evolutionary origin of human-specific genes, extending it to the new list of human-specific cNPC-enriched genes resulting from the inclusion of the Johnson et al., 2015 dataset. As described in the Results and presented in Figure 4, this analysis shows that 13 of the 15 human-specific genes identified here evolved by entire or partial gene duplication. The origin of the other two genes involved exon duplication, leading to a chimeric zinc finger gene, and the removal of a premature stop codon. Therefore, while gene duplication is the main "*genomic remodeling*" evolutionary drive in our dataset, we were able to observe and describe at least two interesting exceptions.

> 11\) Figure S1 -- Bottom panels for PH3 analysis at E14.5 after electroporation 1 day before: the graph and pictures show near-null presence of basal (abventricular) mitoses in control embryos, which is clearly not the case under normal circumstances, especially at this intermediate stage of cortical neurogenesis. How is this possible, even in GFP- cells?

We agree with this criticism of the reviewers. The image shown in Figure S1C left was a single optical section and thus was not really representative. We have replaced the images with more representative ones, which are now shown in Figure 9J.

[^1]: Department of Genetics, Harvard Medical School, Boston, United States.

[^2]: These authors contributed equally to this work.
